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ABSTRACT 
MICHAEL LABRANCHE BERNARD. Structural and Functional Characterization of 
the Activator of G-protein Signaling 3 (AGS3). (Under the direction of STEPHEN M. 
LANIER) 
AGS3 (Activator of G-protein Signaling 3) was isolated in yeast-based functional 
screen for receptor-independent activators of heterotrimeric G-proteins. To examine the 
role of AGS3 in mammalian signal processing, we defined the AGS3 sub domains 
involved in G-protein interaction, its selectivity for G-proteins and its influence on the 
activation state of G-protein. AGS3 co-immunoprecipitated with Gia3 from tissue 
lysates in a nucleotide dependent manner (GDP»GTPyS). The regions of AGS3 that 
bound Gin were localized to 4 thirty amino acid repeats (GPR - G-protein regulatory 
motif) in the carboxyl terminus (P463-S650), each of which were capable of binding Gin. 
AGS3-GPR domains selectively interacted with Gin in tissue lysates and with purified 
Gin/Gtn. The GPR domain of AGS3 containing four GPR motifs simultaneously bound 
more than one Gia. The AGS3-GPR domains competed with Gf3y for binding to 
GtaGDP and blocked GTPyS binding to Gial. When added to reconstituted receptor/G-
protein complex, AGS3-GPR disrupted the high affinity state of the receptor. 
From N-terminus to C-terminus, AGS3 contains a region of seven 
Tetratricopeptide repeats (TPRs), a one hundred amino acid linker region and the GPR 
domain. Using the TPR and linker region as bait, screening a mouse II-day old 
embryonic library using the yeast two-hybrid method yielded the C-terminal 107 amino 
Xlll 
acids (D330-Q436) of a serine/theronine kinase, S/TKII. A GST-S/TKII (D330-Q436) 
fusion protein interacted with AGS3 from rat brain lysate. Ga subunits were also 
detected in this complex in a nucleotide dependent manner. 
To uncover the role of AGS3 in the intact organism we analyzed the function and 
expression profile of the AGS3 homolog in Caenorhabditus elegans. The pattern of 
LacZ staining indicated a strictly neuronal expression pattern for AGS3-CE. The 
expression in sub-adults appeared more widespread compared to that in adults. Using 
double stranded RNA corresponding to the coding region of the predicted AGS3-CE we 
performed RNA interference (RNAi). Injection of double stranded RNA into sub-adult 
worms generated a phenotype with nearly 85% penetrance. Offspring of dsRNA injected 





Heterotrimeric G-protein signaling systems are widely used in nature to convert 
extracellular stimuli into intracellular responses. The machinery of these ubiquitous 
signaling systems consists of seven transmembrane span receptors, heterotrimeric 
guanine nucleotide-binding proteins and their effectors. Throughout evolution, G-protein 
coupled signaling systems transduce a great diversity of extracellular signals. What is 
common to the specific signaling systems is the transfer of information from receptor to 
G-protein to effector. This mode of signal transduction is conserved from 
Saccharomyces cerevisiae to Homo sapiens, yet higher organisms have developed very 
complex G-protein mediated signaling pathways. This complexity can be explained by 
an increase in the variety of receptors, G-proteins and effectors. However, it is apparent 
that other factors beside receptor G-protein and effector can contribute to signaling 
specificity. These factors known as accessory proteins can convert a generic G-protein 
signaling cascade into a specific intracellular response. The understanding of how these 
factor$ integrate into G-protein signaling pathways will greatly facilitate the 
understanding of how specific responses to external stimuli are generated. 
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II. HETEROTRIMERIC G-PROTEIN SIGNALING 
A. DISCOVERY OF HETEROTRIMERIC G-PROTEIN SIGNALING 
Discovery of G-proteins 
The discovery of heterotrimeric G-proteins was the result of efforts to understand 
the mechanisms of hormone-mediated modulations in intracellular cAMP. Using several 
different hormone treatments, Sutherland demonstrated that cells responded by 
modulating levels of cAMP. He also discovered that an integral membrane protein, 
which he termed adenylyl cyclase, was responsible for the conversion of ATP into cAMP 
(1). The discovery of adenylyl cyclase and cAMP as a "second messenger" earned 
Sutherland the Nobel Prize in Medicine in 1971. 
While trying to decipher the mechanism of cAMP regulation, Rodbell and co-
workers learned that the hormones causing similar rises in cAMP levels did not act upon 
the same cell surface receptor (2) and that the receptor was distinct from adenylyl cyclase 
(3, 4). This body of data led Rodbell to hypothesize that a common "tranducer" linked 
receptor stimulati'on and effector activation. Rodbell and co-workers subsequently 
discovered that guanine nucleotides could not only affect ligand receptor binding (5) but 
that GTP was required for AC activation. He postulated that the transducer might be 
regulated by guanine nucleotides (5). 
In 1977 Gilman and co-workers demonstrated that a strain of S49 cells with 
normal amounts of receptor but lacking adenylyl cyclase activity was not deficient in 
aden yl yl cyclase itself. They resolved the components of AC into a stimulatory 
component and a catalytic component. They showed by reconstitution experiments that 
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the adenylyl cyclase catalytic component from cyc- S49 cells was not deficient in 
activity. The deficiency was in the stimulatory component of adenylyl cyclase, a guanine 
nucleotide binding protein called the GIF factor (6, 7). In 1980 Northrup and Sternweis, 
working in the lab of Gilman, purified the GIF factor and named it Os for stimulatory 
guanine nucleotide binding protein (8). Findings from the Gilman laboratory agreed with 
the discovery by Rodbell that GTP was a requirement for receptor mediated AC 
activation. The discovery of a guanine nucleotide binding protein acting as a stimulatory 
factor advanced the concept of an intermediary between receptors and AC. Thus began 
the paradigm of G-protein mediated signaling pathways: Receptor to G-protein to 
Effector. Alfred Gilman and Martin Rodbell won the Nobel Prize in Medicine in 1996 
for their work leading to the discovery of G-proteins. 
G-proteins as heterotrimers 
Other guanine nucleotide binding proteins were demonstrated to play a role in 
signal transduction pathways. Sutherland noted inhibition of AC by certain hormones 
(1). Stimulation and inhibition of hormonal-mediated AC activity were blocked by 
cholera toxin (9) and pertussis toxin (10), respectively, which modified different 
substrates (11). The pertussis toxin substrate was purified simultaneously by Gilman's 
(12) and Manclark's (13) groups as a guanine nucleotide binding protein, and was later 
named Gi (14). Also present in the purification preparations of Gi was a 36 kDa protein 
previously detected in the purification of Gs. This protein was considered a subunit of 
the Gs/Gi complexes and named Gbeta (G~); the guanine nucleotide binding subunit was 
termed Galpha (Ga). After eluding many scientists by running in the dye front, another 
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component of both Gs and Oi was discovered, a 7 kDa protein named G-gamma (Gy) 
(15). Thus Os and Gi were subsequently known as heterotimeric G-proteins. 
Signaling through heterotrimeric G-proteins: a common mechanism 
In 1977 Wheeler, working with photo-transduction in the retina, separated a GTP 
binding protein and demonstrated that it activated cyclic GMP phosphodiesterase (16, 
17). This finding led to the discovery of transducin, which was composed of three 
subunits alpha, beta and gamma (18). The 41 kDa alpha subunit was the guanine 
nucleotide binding component of transducin, shown to be the transducer of information in 
the light-triggered signal cascade (19). These findings also demonstrated that, upon 
activation of the signaling cascade, the heterotrimer dissociates into the alpha subunit and 
the beta-gamma heterodimer. This paradigm fit well with the proposed mechanism of 
hormonal mediated cAMP regulation. Indeed, when the alpha subunits of transducin (Ot) 
(20-22) and Gs (23, 24) were cloned, significant homology was found between the two 
proteins. This suggested a common mechanism of signal transduction mediated by 
heterotrimeric G-proteins. 
B. DIVERSITY OF HETEROTRIMERIC G-PROTEINS 
Gasubunits 
Heterotrimeric G-proteins consist of an alpha, beta and gamma subunit. The 
number of reported alpha subunits in mammalian genomes range between 16 and 20 (25-
27). Results from the human genome project indicate as many as thirty Ga genes may 
exist in the genome (28). Alpha subunits can be classified into 4 families: the Os, the Gi, 
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the Gq and the G 12 families (Table 1.1). The Os family consists of three members that 
act by stimulating AC activity and/or regulating calcium channels (8, 27, 29). The Oi 
family contains nine members that act upon various effectors. The Oq family contains 
five members that act upon PLCJ3 (30). The most recently discovered family, 012/G13, 
signals through a Rho GEF (31) and can modulate Na+lH+ exchange (26, 32). C. 
elegans and D. melanogaster genomes have members of each Ga. family, suggesting the 
importance of the different Go. families throughout evolution (33). 
The Gi family deserves special attention since AGS3 displays preference for this 
class of alpha subunits. Although sequence similarity and pertussis toxin sensitivity 
group the nine Oi members into one family, there are distinct divisions among the 
members. Of the nine, only three are called Gio. (Gia.1, 2, 3). Gia. proteins negatively 
regulate AC and can mediate several effectors through their J3y subunits. The pair of Gta. 
proteins is distinct due to their limited expression in the retina and their coupling to the 
light triggered receptor rhodopsin (18). Gustducin (Ggusta.) most closely resembles 
transducin; however, its role is limited to another sensory system, taste (34). Of the two 
Goa. proteins the Goa.1 subtype is more prevalent. Goa. is highly expressed in brain and 
has been calculated to comprise up to 1 % of brain membrane protein (14, 35). One of the 
many mysteries of heterotrimeric G-protein signaling is the role of the copious amounts 
of GOf;X.in mammalian brain tissue. Several effectors have been ascribed to activation by 
Goa.; however, the mechanisms of action indicate that the effects are mediated through 
the ~y subunits (36). Gza. is distinguished from the rest of the Gi family by pertussis 
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Table 1.1 Ga families and their effectors. 
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diverse Oa family in mammals as well as in lower organisms. In C. elegans, 16 of the 20 
alpha subunits can be classified as Gi subunits (33). 
Gp subunits 
There are 5 O~ subunits, as well as one splice variant of 0~5 containing a C-
terminal extension (27, 40). 0131-4 share -80% similarity, whereas 0135 is only 50% 
similar to the others. 0135 also differs in its restriction to the CNS and its greater 
likelihood to be localized to the cytosol (27). Initially, the beta subunit was not thought 
to engage effectors; rather it was shown to be a required component of OPCR-mediated 
GTP hydrolysis and a factor necessary for receptor-On interactions (41-43). Logothetis 
(44) demonstrated that· Ol3y subunits could activate muscarinic K+ channels, opening up 
new areas of research for the Ol3y subunit. Subsequently, the O~y subunit has been 
implicated in the activation and/or inhibition of numerous effectors, such as certain AC 
isoforms (45), PLC~ (46, 47) (48), PLA2 (49, 50), PI3 Kinase (51), GIRK channels (52) 
and MAPK (40). In lower organisms such as Saccharomyces cerevisiae (53) and 
Dictyostelium (54) the GJ3y subunit is the primary signal transducer. Recently, the beta 
subunit in C. elegans was found to mediate mitotic spindle rotation in early 
embryogenesis (55). 
Gysubunits 
Thirteen 0 gamma subunits have been identified (56), yet the functional roles of 
these subunits have not been definitively resolved. By binding to the beta subunit, the 
gamma subunits stabilize GJ3s. Since G~ is not modified by fatty acid, the lipid 
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modifications of the Gy subunit are thought to indirectly tether GI3 to the plasma 
membrane. Some evidence of Gy conferring receptor-effector specificity exists however 
this may be a specialized function as opposed to a common rule (57). The extensive 
modifications of Gy subunits has led some to hypothesize that the thirteen y subunits and 
all of the possible modified forms of those subunits play a role in signaling specificity 
(57). 
c. MECHANISMS OF G-PROTEIN SIGNALING 
Receptor to G-protein to effector 
The discovery of G-proteins provided proof for a direct link between extracellular 
stimuli and intracellular responses. Findings of various G-protein families and their 
respective effectors, not to mention the myriad of cell surface receptors coupling to G-
proteins, made it clear that this signaling motif was well-utilized by nature. Although 
receptors, G-proteins and effectors can vary dramatically, the transduction of information 
through G-protein signaling cascades uses many of the same core steps. Generally, 
activation of a cell surface receptor leads to nucleotide exchange on the alpha subunit, 
thus activating the G-protein. Active G-proteins stimulate their effectors until GTPase 
activity returns them to the inactive heterotrimer. Based on early G-protein research, the 
emerging paradigm of G-protein signal transduction was that signaling information 
transferred from receptors to G-proteins to effectors. 
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The ActivationIDeactivation Cycle of G-proteins 
Measurements of the rates of G-protein activation were facilitated by the use of 
guanine nucleotide analogs and radiolabeled probes (58-60). These studies allowed for a 
detailed mechanism to be mapped for signal transduction through G-proteins (Figure 
1.1). G-protein signaling is initiated by a stimulus dependent conformational change in a 
G-protein coupled receptor (GPCR) (60). Some debate exists as to whether the G-protein 
is pre-coupled to the un-stimulated receptor (61), or whether G-proteins are recruited to 
activated receptors (62). One receptor can activate multiple G-proteins (63, 64). 
Regardless, the GPCR conformation change induces the inactive heterotrimer to undergo 
nucleotide exchange. GDP bound to the alpha subunit dissociates leaving a temporary 
empty state on the alpha subunit (65). Since GTP is in vast excess over GDP, the 
guanine nucleotide triphosphate that binds to the alpha subunit (66). Go. subunits bound 
to GTP lose their affinity for receptor and for GJ3y heterodimers, and gain affinity for 
their effectors (67, 68) GPy subunits do not undergo a change in conformation. Instead, 
liberation from the heterotrimer allows GPy to engage effectors (69). Activation of Go. 
effectors terminates when the intrinsic GTPase activity of the alpha subunit catalyzes 
hydrolysis of the GTP gamma phosphate, thus returning Go. to the GDP bound state (6, 
70, 71). The current model of GJ3y signaling suggests that when a free Ga.GDP complex 
re-associates with GJ3y to form an inactive heterotrimer, the GJ3y signal is terminated (70-
72). Discrepancies in GTPase rates between purified G-proteins and membrane fractions 





GaGTP + GJiy 
t 
Effectors 
Figure 1.1 G-protein activation/deactivation cycle. Heterotrimeric G-proteins are activated 
by agonist bound G-protein coupled receptors. Receptor stimulation of G-proteins causes the 
alpha subunit to dissociate GOP from its nucleotide binding site, allowing for binding of GTP. 
GTP-bound alpha subunits lose affinity for Gl3y heterodimers. Liberated Gl3r and GTP-bound 
Go. act on effectors. The intrinsic GTPase activity of the alpha subunit hydrolyses the gamma 
phosphate to return the alpha subunit to the GOP bound form. Gu-GOP and GPr then re-
associate to form heterotrimers. 
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III. ACCESSORY PROTEINS AND G-PROTEIN SIGNALING 
Signals initiated by extracellular ligands often go through a tortuous path to 
generate their specific cellular response. In the case of G-protein mediated signals, 
information is transferred from seven transmembrane span receptors to heterotrimeric G-
proteins to effectors. Nature has employed this mode of transduction in many signaling 
systems, using the myriad of GPCR, G-protein and effector combinations. However, 
signaling specificity involves not only the selective activation of a particular effector. In 
addition to selective effector activation, signaling specificity can be influenced by: 1) the 
duration of signal, 2) the amplitude of signal, 3) the localization of signal and/or 4) the 
cell-specific expression of signaling components. While the many permutations of 
receptor, G-protein and effector combinations confer a significant degree of specificity, 
other factors beside the core components of G-protein signaling may be influencing 
signaling specificity. Thus, the identification and isolation of these factors tenned 
accessory proteins has been a major area of interest in our laboratory. 
A. DISCOVERY OF ACCESSORY PROTEINS 
Early evidence for accessory proteins 
Accessory proteins are factors other than receptor, G-protein or effector that can 
modify signaling specificity of G-protein signaling pathways. Early reports of additional 
factors influencing signaling specificity came from diverse areas of G-protein signaling. 
Historically, accessory proteins to G-protein signaling were generally under-appreciated. 
Their discovery was usually a serendipitous result of studies with G-protein signaling 
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systems. Benovic, working in Lefkowitz's laboratory, purified a protein that 
phosphorylates f32-AR in the presence of agonist (73). This protein, BARK, is a member 
of a family of six G-protein receptor kinases (GRKs) that act to initiate desensitization 
and, in some cases, sequestration of most GPCRs. Another GPCR accessory protein, f3-
arrestin, was likewise discovered in the Lefkowitz laboratory (74). Arrestins bind to 
phosphorylated GPCRs, thereby uncoupling receptors from G-proteins and mediating 
receptor sequestration (75). 
Several alternate binding partners of G-proteins were discovered. Calmodulin 
interacts with GJ3y and affects its regulation of AC (76). Enriched in growth cones of 
neurons, neuromodulin or growth associated protein-43 (GAP-43) increases the rate of 
GTPyS binding to the predominant G-protein in brain, Goa (77). In the retinal system, 
phosducin negatively regulates signaling duration by sequestering Gf3y away from its 
effector (78). Another lead suggesting the existence of G-protein regulatory proteins 
stemmed from observations of enhancement of Oa GTPase activity by PLC and cGMP 
PDE (79, 80). Although both are known effectors, they provided the first evidence of 
proteins that could affect the intrinsic GTPase rates of Ga subunits. One of the first 
proteins known to affect the localization of G-protein signaling proteins was caveolin a 
protein that forms subcellular structures in specialized cholesterol rich lipids (81, 82). 
These lipid rafts are rich in a wide array of signaling proteins, including components of 
G-protein signaling systems. Cross-linking studies from the Rodbell laboratory showed 
that G-proteins interacted with F-actin and tubulin suggesting a link between the 
cytoskeleton and heterotrimeric G-protein signaling (83). All these findings germinated 
13 
the idea that G-protein signaling operated within the context of a complex of signaling 
components that could determine signaling specificity. 
The Search for Accessory Proteins 
The numerous possible combinations afforded by the diversity of GPCRs, G-
proteins and effectors imply that nature uses subtypes of the core signaling components 
to generate signaling specificity. While this notion was implicit, Dr. Lanier's laboratory 
was one of the earliest to examine factors that determine signaling specificity. This body 
of work engendered the idea of accessory proteins to G-protein signaling. Initially, 
subtypes of the a.2-AR were examined for their ability to couple to different G-proteins 
using Nlli-3T3 cells stably expressing a.2b, a,2c and a2d-ARs (84). Findings that a2c-
ARs exhibited differential G-protein coupling and efficiency of signaling properties 
compared with the other a.2-ARs (84) were complemented by the finding that the a2c-
AR preferentially coupled to Goa. subunits (85). The use of stable transfectants in both 
studies as opposed to using reconstituted systems were in part prompted by the desire to 
create a "natural environment model" (85). Lanier noted that cellular factors possibly 
influencing receptor signaling might be lost in such reconstituted systems. 
Continuing the investigation of factors contributing to signaling specificity, Duzic 
and Lanier reported cell-specific coupling of a,2-ARs to adenylyl cyclase (86). NllI-3T3 
and DDTI-MF2 cells expressing a.2-AR SUbtypes responded to epinephrine treatment 
with AC inhibition. However, PC-12 cells expressing a,2-AR subtypes demonstrated a 
dose-dependent increase of cAMP with epinephrine treatment. The calcium chelators 
BAPTA and EGTA blocked a2-AR-niediated AC activation in PC-12 cells. Analysis 
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indicated the expression of Ca++/CaM sensitive AC isoforms in PC-12 cells but not in 
DDTl-:MF2 and NIH-3T3 cells. These findings suggested that one receptor sUbtype 
could couple to different effectors. Sato and co-workers generated a reconstitution 
system using purified heterotrimeric G-proteins and membrane fractions from PC-12 and 
NIH-3T3 stable transfectants (87). G-protein activation was measured in membranes 
from cells expressing the same receptor (a,2-AR) that were exposed to the same pool of 
G-proteins. A 3-9 fold enhancement of pertussis toxin-sensitive G-protein activation was 
found in PC-12 cells in comparison to the G-protein activation observed in NIH-3T3 cells 
expressing the same receptor at the same receptor density. Speculating that PC-12 cells 
contained an additional factor contributing to G-protein activation, Sato and co-workers 
identified a detergent-soluble factor capable of stimulating GTPyS binding to G-proteins 
that was present in PC-12 cells but not in NIH-3T3 cells. Thus, G-protein activation in 
PC-12 cells could be modified by a non-receptor, non-G-protein factor. These findings 
initiated the search for factors, termed "accessory proteins", distinct from receptor and G-
proteins, that modify the transfer of signal from receptor to G-proteins or that modify G-
proteins independent of receptor stimulation. 
RGS Proteins 
Regulators of G-protein Signaling (RGS) proteins are a family of Ga GTPase 
Activating Protein or GAPs. Their presence and diversity throughout evolution suggests 
that G-protein signaling is a favored motif that serves as a core upon which a complex set 
of regulatory machinery is built. Their discovery ushered in a new understanding of how 
signals through G-proteins are regulated, and confirmed the importance of accessory 
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proteins. The first RGS proteins were discovered in the model organisms S. cerevisae and 
C. elegans. Dohlman and co-workers found that SST2 (super sensitive to pheromone) 
was a negative regulator of the G-protein mediated Saccharomyces cerevisiae pheromone 
response cascade (88). In C. elegans, egl-10 was identified using a genetic screen as a 
gene responsible for proper rate of egg laying (89). The suppressed rate of egg laying by 
egl-10 mutants contrasted with the elevated levels of egg laying in Goa. (goa-l) mutants, 
suggesting that egl-10 acted as a negative regulator of G-protein signaling (90, 91). 
Analysis of the egl-10 sequence revealed significant similarity with portions of sst-2, 
implying conservation of a protein domain responsible for G-protein regulation (89). 
When GAIP, a mammalian protein identified as a Gia.3 interacting protein using the two-
hybrid method, was found to contain similarity to the shared regions of 'EGL-I0 and 
SST2, a family of proteins was born (92). 
The name regulator of G-protein signaling (RGS1) was given to a gene up-
regulated in lymphocytic leukemia. RGS 1 containied the 120 amino acid domain found 
in GAIP, EGL-I0 and SST2 (93). The common domain became known as the RGS core 
domain and was used a marker for putative G-protein regulators. Currently 19 
mammalian RGS proteins have been identified, largely based on the presence of the RGS 
domain (94, 95). 
Classification of accessory proteins 
Accessory proteins refers to a collection of proteins distinct from receptor, G-
protein and effector that modify G-protein-mediated signaling events. They can 
generally be categorized into one or more of the following four groups: '1) receptor 
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regulators, 2) signal propagators/integrators, 3) receptor binding proteins and 4) G-
protein binding proteins (Table 1.2). Receptor regulators are proteins that modify G-
protein-coupled receptors and in tum affect the signaling properties of the receptors. 
Many of the receptor regulators are receptor kinases like GRKs (96), protein kinase AlC 
(97) and casein kinase (98, 99). Another receptor regulator, arrestin, leads to 
desensitization by binding to phosphorylated GPCRs (100). Other receptor regulators 
include phosphatases (101) and the receptor transport and specificity co-factor RAMPs 
(102). 
The second group, signal propagators/integrators, contains proteins that either 
confer specificity to signaling pathways or are required for the propagation of signal. 
Two proteins, Calcyon and the CGRP component protein, represent signal-specifying 
proteins. Calcyon binding to the Dopamine D1 receptor can alter coupling of 
downstream effectors (103). The CGRP component confers responsiveness to CGRP 
(104). Signal propagators such as CRAC, Pianissimo, Rip3 and Aimless are required for 
the transfer of signal between G-proteins and their effectors (105-108). 
The third group contains a diverse set of proteins known to interact with G-
protein coupled receptors, although the purpose of some of the interactions has yet to be 
determined. Some examples of receptor interacting proteins include calmodulin (109), 
14-3-3 (110), endophilin (111) and spinophilin (112). Wu and co-workers discovered 
that Gl3y binds to the third intracellular loop of m3 muscarinic receptors (113). AGS2, or 
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Tctex 1 (AGS2) 
Group I Receptor Regulators 
Binds to phosphorylated receptor; signal termination 
Phosphorylates M3 muscarinic receptor 
Influences stability of receptor-O-protein complex 
De-phosphorylate receptors 
Phosphorylate selected receptors 
Phosphorylate activated receptors 
Regulate receptor traffickinglligand recognition 
Inhibits rhodopsin kinase 
Group n Signal propagation/integration 
Required for receptor coupling to AC (D. discoideum) 
Binds to D 1 dopamine receptors; Ca signaling 
Confers responsiveness to CGRP 
Required for receptor coupling to AC (D. discoideum) 
Required for receptor coupling to AC (D. discoideum) 
Links IP3 receptor and metabotropic glutamate receptors 
Rhodopsin; Multiple PDZ protein forms R-G-E complex 
Required for receptor coupling to AC (D. discoideum) 
Required for receptor coupling to AC (D. discoideum) 
Enhances activity of 5HT2 receptors 
Group ill Proteins that interact with receptor 
a2AR-i3 loop; receptor localization 
Crosslinks actin & D2 dopamine receptor i3 loop 
A T1 receptor; interferes with PLC coupling 
mGluR c-terminus and D2 dopamine receptor i3 loop 
SSTR2 somatostatin receptor and actin binding protein 
~1-AR; influences receptor internalization 
i3 loop of M2R, M3R and a 2AR; C-terminus of mOluR 
D4 dopamine i3 loop; receptor internalization 
Adenosine 1 receptor; interferes with R-G coupling 
Adenosine 2b receptor ligand 
J32AR c-terminus; mediates 132 control of H+/Na+ exchange 
Co-immunoprecipitates with M3 muscarinic receptors 
Crosslinks D2 dopamine receptor i3 loop, protein phosphatase 1 
SSTR2 c-terminus; receptor localization 
Rhodopsin c-tenninus; receptor trafficking 


























Group IV Proteins that interact with G.proteins 
Gia.; Increases GTPgS binding to Gi, Go 
GJ3y 
GilGt; GDI for Go. subunits 
Goa; C-terminus stimulates GTPyS binding to Goa. 
Goa.; binds f3-app and mediates Goa activation 
Gqa., G 12a., G(3y 
Ga. subunits; N-tenninus inhibits GTPyS binding 
Gqa., Gia. 
Goa.; stimulates GTPyS binding to Goa., enriched in growth cones 
Goa, Gza.; binds to activated Go. subunits 
Gqa., binds to activated Ga., contains RGS-like domain 
Gia.3, Gia.2, Goa; AGS3 family member 
Gia.3 
GI2a., GI3a.; Acts as effector and GAP 
Gia.2 (ba.; GPR containing protein with GD I activity 
GJ3y; impedes heterotrimer formation 
Giloa; AGS3 family member, asymmetric cell divisions 
Gza., GI2a.; phosphorylates Go. subunits 
Goa.; C-terminus activates GTPyS binding to Goa. 
Goa, Gza., Gia. 
Gia, Gqa, GI2113a. families; Family of Ga. GAPs 
Gia, Gsa; activated by Ga. subunits 
G(3y 
Gia.; Stimulates nucleotide exchange 
Table 1.2 Accessory Proteins for G"protein signaling. (continued) 
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The final group consists of G-protein interacting proteins. Some of these proteins 
are only known to interact with G-protein subunits, but are not known to influence G-
protein activity. Proteins interacting with GJ3y include AGS2 (115), phosducin (78) and 
syntaxin 1A (116). Compared to GJ3y binding proteins, Go; binding proteins are much 
more prevalent. Proteins such as nucleobindin (117), eya2 (118) and Rap 1 Gap (119) 
interact with Go.; however, they are not known to influence the activation state of the 
alpha subunit. The subset of proteins that can regulate the activation state of G-proteins 
are classified as G-protein regulators. The identification and characterization of G-
protein regulators is the major area of research in Dr. Lanier's laboratory and were the 
focus of my efforts. 
B. G-PROTEIN REGULATORS 
G-protein regulators are the subset of accessory proteins that can influence the 
activation-state of G-proteins independent of receptor stimulation. These proteins add 
complexity by allowing non-receptor stimuli to influence G-protein signaling. 
Monomeric G-proteins are predominantly regulated by proteins known as guanine 
nucleotide exchange factors, GEFs, and GTPase activating proteins, GAPs (120). GEFs 
generally activate monomeric G-proteins by inducing the formation of the GTP bound 
state. GAPs act in contrast by catalyzing GTP hydrolysis, returning the monomeric G-
protein to the inactive or GDP bound state. Therefore small G-protein activity is 
regulated by opposing proteins, GEFs and GAPs. Other factors such as guanine 
nucleotide dissociation inhibitors (GDIs) have been described for small G-proteins (121). 
20 
Heterotrimeric G-proteins are also regulated by GEFs and GAPs. Activated G-
protein coupled receptors act as GEFs for heterotrimeric G-protein. Ga subunits have 
intrinsic GTPase activity, a feature not shared by small G-proteins. Therefore the alpha 
subunit alone can act as a negative regulator of its own activity. However, another class 
of proteins, the RGS family, functions as negative regulators of G-protein signaling. 
They do not have GTPase activity, but can increase the rate of intrinsic GTPase activity. 
Besides receptors, very few proteins have been shown to act as Ga GEFs. Likewise, few 
proteins besides RGS or RGS-like proteins negatively regulate Ga activity. The N-
terminus of caveolin 1 was reported to be a GD! for heterotrimeric G-protein, the first 
such protein known (81); the corresponding region of caveolin 3 acts as a Ga GEF (82). 
GTPase Activating Proteins- GAPS 
Before the discovery of the RGS family, it was proposed that SST2 might act as a 
Gpa1 GAP (88). Berman, working in Gilman's laboratory, demonstrated that GAIP and 
RGS4 do not act as exchange factors but do stimulate the GTPase rates of purified Gia 
subunits (122). The effect was not observed for Gsa. Subsequently, RGS proteins have 
been shown to act as GAPs for Gqa (123), Gza (124, 125), Goa (89) and 012/130. (31). 
A major physiological role of ROS proteins is speculated to be regulation of the 
duration andlor amplitude of G-protein signaling cascades. Although the family of RGS 
proteins contains a common 120 amino acid core domain, they can vary greatly outside 
this region (Figure 1.2) (95). Variation in RGS proteins likely generates specificity 
among the family. RGS proteins such as SST2 and EGL-IO down-regulate G-protein 
activity, but some RGS proteins in higher organisms are involved in fine-tuning of G-
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Figure 1.2 Mammalian RGS proteins. Left: A cladogram ,constructed from amino acid 
sequence identities within the RGS domain defines five subfamilies RZ, R4, R7, R12, and RA. 
The scale shows , approximate amino acid identity calculated as 100% minus the sum of the 
horizontal distance to and from the common branch point (e.g. 'axin and conductin are 64% 
identical). All sequences are human except for RGS8 (rat), RGSZ2 (mouse)" and RET-RGSI 
(bovine). Right: Most proteins within each subfamily are also ho~ologous in regions flanking 
the RGS domain; homologies include definable functional domains shown as labeled blocks on 
the diagrams of each protein's structure. Abbreviations: APC,. ~denomatous polyposis coli; 
GGL, G-like; DEP, PDZ, and PTB, protein interaction domains; PP2A, protein phosphatase 2A. 
Adapted from Ross, E.M. and Wilke, T. Annual Review of Biochemistry. 69: 795-827, 2000. 
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protein signals. RGSS can accelerate not only the rate of GIRK channel activation, but 
also the rate of inactivation, providing for a sharp response to GPCR agonists (126). A 
sub-group of RGS proteins (RGS 6,7, 9, 11) can interact with G~5 subunits through a 
domain weakly similar to Gy subunits (127, 12S). Slepak and co-workers found that G~5 
co-purified with RGS7 in cytosolic fractions of the retina (129). These findings were 
supported when Siderovski and co-workers used computer ·prediction to find a domain 
within RGS proteins containing similarity to Gy named the G-gamma like domain (GGL) 
(12S). Proteins in this subgroup of RGS proteins form heterodimers with G~5 subunits, 
thereby raising interesting questions about signaling through non-traditional 
heterotrimers. RGS12 and RGS14 are the largest RGS proteins with several distinct 
protein motifs including the GoLoco or GPR domain (115, 130). After the initial RGS 
proteins were isolated, the remainder of the family was discovered based upon the 
conserved RGS core domain. Lowering the stringency of search parameters, several 
groups found RGS-like domains in some interesting proteins. 
Non-RGS GAPS 
G-proteins GAPs are not limited to the RGS family. Before the RGS proteins 
were discovered, several factors were known to have GAP activity. Some of the earliest 
known Ga. GAPS were in fact effectors. As mentioned before, the Gq effector PLC-13 
and the Gta. effector cGMP PDE (79, SO) were described to have GAP activity. Recently 
the Ga.12/13 effector p115RhoGEF was shown to have GAP activity for Ga.13 (31). 
Closer inspection of both PLC-13 and p115RhoGEF sequences revealed regions 
corresponding to Ga. binding domains with weak similarity to the RGS domain (31, 95). 
23 
These domains have recently been dubbed RGS-like or RGL domains (95). Other 
proteins with this domain include GRK2, GRK3 (131, 132), axin (133) and conducin 
(134); however, the latter two proteins do not have GAP activity for Ga subunits. 
Neither GAP activity nor a RGL domain was detected in cGMP PDE. The gamma 
subunit of cGMP PDE stimulates the activity of a RGS9-GJ35 heterodimer thus indirectly 
stimulating GTPase activity of Gta (135). The existence of effectors having GAP 
activity blurs the distinction between core signaling components and G-protein 
regulators. Effector-GAPs themselves provide a degree of signaling specificity by 
regulating the conversion of signal from G-protein to effector. In these signaling 
pathways, one activated G-protein presumably activates one effector molecule and is then 
inactivated, providing for rapid responses to signal termination. 
Heterotrimeric G-protein GEFs, Guanine nucleotide exchange factors 
Heterotrimeric G-protein GEFs stimulate the exchange of GDP for GTP on Ga 
subunits. The most predominant group of Ga GEFs is agonist bound G-protein coupled 
receptors. However, since they are core components of G-protein signaling, they do not 
qualify as accessory proteins. Reports of non-receptor Ga. GEFs are relatively sporadic 
as compared to those of Ga. GAPs,. A handful of proteins have been described as GEFs, 
but do not share any sequence simllarity. The most well-known Oa GEF is GAP-43, or 
neuromodulin. OAP-43 co-localizes with and activates Goa. in neurons (77). The 
cytoskeletal protein tubulin is a G-protein GEF for Gin (136, 137). Two proteins 
involved in familial Alzheimer's disease, J3-amyloid precursor protein (138) and 
presenilin-l (139), are G-protein OEFs. The cytoplasmic tails of both proteins activate 
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the major brain G-protein, Goa. Recently BBPs (f3-amyloid binding proteins), a family of 
GEFs, were identified as cofactors in f3-APP-mediated activation of Goa. Based on 
homology searches, BBPs displayed significant similarity with the second intraceillar 
loop of GPCRs (140). Non-OPCR mediated extracellular signals acting through Ga 
activating proteins could function through cross-talk with G-proteins. Signals initiated 
within the cell might stimulate Go. GEFs, leading to G-protein cascades. G-proteins 
activated by GEFs might behave or couple differently than those activated by G-protein-
coupled receptors. GEFs might act in concert with GPCRs to provide a synergistic effect 
of Ga activation. Basal G-protein activity might also be mediated by GEFs. These 
intriguing possibilities, along with the relatively few numbers of OEFs reported in the 
literature, stimulated the search for G-protein activators by our laboratory. Our 
development of a biochemical assay to detect G-protein activators facilitated the 
discovery of a novel G-protein GEF, the NO-108 activator. 
IV. IDENTIFICATION OF G-PROTEIN ACTIVATORS 
A. BIOCHEMICAL SCREEN FOR G-PROTEIN ACTIVATORS 
The discovery of G-protein regulators, and in particular non-receptor G-protein 
activators, has been a major focus of study in Dr. Lanier's laboratory. Initial 
observations of G-protein activators came from work led by Sato describing a factor in 
PC-12 membranes capable of stimulating GTPyS binding to G-proteins (87). Sato then 
extended his search by analyzing membranes from several cell lines (141). Detergent-
solubilized membranes from NG-108 cells were capable of stimulating GTPyS binding to 
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brain O-proteins up to 4-fold. PC-12 membranes increased GTPyS binding by -1.5 fold. 
Membranes from Nlli-3T3 and C6B4 cells did not show appreciable activation of OTPyS 
binding. Characterization of the NG-I08 activator revealed that it was distinct the 
following G-protein OEFs: neuromodulin, tubulin, caveolin and f3-amyloid precursor 
protein. The NG-I08 activator activated both Goa and purified bovine brain heterotrimer 
with greater efficiency than Gin. Activity of the NO-I08 activator is pertussis toxin-
insensitive suggesting that it uses an alternate mechanism of O-protein activation 
compared to O-protein coupled receptors (C. Ribas personal communication). Ribas 
sought to purify the factor responsible for O-protein activation, but only resolved the 
activity to 4-5 proteins. Currently, efforts are underway to sequence protein bands 
isolated from SDS-PAGE of the purified fractions. Limited success with partial 
purification of the NG-I08 activator led our group to search for alternative methods to 
purify the protein responsible for G-protein activation. 
B. YEAST EXPRESSION CLONING SCREEN 
Takesono and Lanier initiated a collaboration with Cadus Pharmaceutical 
Company in Tarrytown, New York in hopes of identifying the NO-I08 activator. Cadus 
specialized in custom yeast strains designed for analysis of G-protein mediated signaling. 
The knowledge of the yeast genome and the ease of genetic manipulation made 
Saccharomyces cerevisiae an attractive model organism to use. In addition the O-protein 
coupled pheromone response pathway in yeast is well-defined and relatively simple 
(Figure 1.3). The goal was to screen a cDNA library from NO-lOS cells for entities that 
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Figure 1.3 Pheromone response pathway and the Saccharomyces cereVlswe expression 
cloning system. ' The above panel depicts the pheromone . response pathway ' used by 
Saccharomyces cerevisiae. ' The bottom panel includes ' the modifications used to identify 
receptor-independent activators of G-protein signaling. The strahl shown in the bottom. panel 
lacks the pheromone receptor, and contains a modified mammalian' G-protein, Gia2Gpal(I-41), 
in the place of the endogenous Gpal. Downstream activation of the pathway was altered by 
knocking out the transcription factor Farl and introducing a FUSl::HIS3 transgene. Activation 
of the pathway would therefore result in HIS3 production confering nutritional selection. 
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also needed to able to activate G-proteins independent of receptor stimulation. To 
accomplish this goal, several modifications were made to components of the pheromone 
response pathway (Figure 1.3) (142). The pheromone receptor and the endogenous Ga 
protein, GPA-l, were knocked out. A mammalian-yeast chimeric G-protein containing 
the first 41 amino acids of GPA-l and amino acids 42-351 of human Gia2 was 
introduced. The chimera allowed a more efficient heterotrimer to form. Downstream 
activation of the pathway normally stimulated growth arrest and mating preparation by 
activating the transcription factor, Par-I. To tailor the system, a Fusl promoter-His3 
transgene was introduced into farl- his3- yeast strains. Activation of the system would 
therefore induce expression of His3 and confer activation-dependent selection. Thus, 
activation of the pheromone response in the modified yeast system resulted in histidine 
selective growth. The eDNA library vector, pYES2, contained a galactose-inducible 
promoter to allow for induction of library expression. 
Takesono and co-workers generated a eDNA library from NG-I08 cells and 
transformed this into the modified yeast strain. After a series of selections and replica 
plating, three clones were isolated: #34, #37 and #53. Epistasis experiments were 
performed to evaluate where these clones acted in the pheromone response pathway. 
Clones #37 and #53, but not clone #34, were shown to activate the system at, or upstream 
of, G-proteins (115). In a similar screen of a human liver eDNA library, a eDNA capable 
of activating the system at, or upstream of, G-proteins was isolated (143). This protein 
was named AGSI for Activator of G-protein Signaling 1. Clones #37 and #53 from the 
NG-I08 screen were named AGS2 and AGS3, respectively. 
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c. AGS PROTEINS 
AGS proteins are a group of proteins isolated in a genetic screen selecting for 
activators of G-protein signaling. Analysis of AGS primary sequences revealed no 
structural similarity among the three proteins; likewise further analysis using the yeast 
system showed that each AOS protein utilized a distinct mechanism of G-protein 
activation. Using different On subunits in the initial screen, AGS1 and AOS3 
preferentially activated Gin2 and Gin3 subunits, while AGS2 did not show any 
preference for any particular On subunit (Figure 1.4). Since G-protein activation is 
typically mediated through nucleotide exchange, a Gia2 mutant (G204A) incapable of 
binding GTP was introduced into the system to determine if Gn activation was required 
for each protein. Likewise, AGS activity was tested in strains over-expressing the Ou 
GAP, ROS4, to verify the requirement of On activation. Interestingly, only AOS1 
activity was abolished in both the 0204A and RGS4 strains, suggesting that AOS2 and 
AGS3 activated G-proteins by a mechanism distinct from nucleotide exchange (Figure 
1.5, data not shown for AOS1) (115). Therefore, each AOS protein displayed a distinct 
mechanism of action in the yeast system. AOS 1 activated Gia2 and Gia3 heterotrimers 
and putatively activated the system by stimulating nucleotide exchange. AGS2 did not 
have a preference for On activation, nor did AOS2 utilize nucleotide exchange for G-
protein activation. AOS3 stimulated Gin2 and Gia3 subunits and did so without 
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Figure 1.4 Selectivity of A GS proteins for different Ga proteins. A ~-galactosidase reporter gene was used to reflect 
activation of the pheromone response pathway. The top left panel makes a relative comparison of the strength of each AGS 
protein in activation of the pheromone response pathway. The bioactivity of AGSl-3 was determined in yeast strains expressing 
different Ga subunits. The Gpal, Gia2Gpa1(1_41)' Gia3Gpa1 (1_41) and Ga16Gpa1 (1-41) yeast strains expressed similar amounts of G-
protein as determined by immunoblotting with Gpal-specific antisera. Data are presented as the mean ± S .E.M of three 




















Figure 1.5 Mechanisms of G-protein activation by AGS3. The expression cloning system was modified to test the effects of 
RGS over-expression and a guanine nucleotide binding-deficient Gia2 (G204A) on AGS activity. Protein expression was 
confirmed by immunoblotting. AGS2, AGS3 and empty vector pYes2 were evaluated in three yeast strains: WT, G204A Gia2, 
RGS4. WT - wild type strain containing Gia2 as described for the original yeast screen. G204A Gia2: Yeast expression cloning 
system expressing a nucleotide binding deficient Gia2 subunit. RGS4: yeast expression cloning system overexpressing RGS4. 
Control plates represent growth on non-selective media. Selection plates are deficient in histidine. Expression of p Yes2 inserts is 
regulated by a galactose inducable promoter. Non-induced and induced are plates containing glucose and galactose respectively. 
Similar results were obtained in three experiments. 
been generated. Since AGS1 was discovered in a screen initiated by Cadus, I initially 
focused upon characterization of AGS2 and AGS3 outside of the yeast system. 
AGSI 
AGS 1 was isolated in the yeast expression cloning system as a 843 nt cDNA. 
Sequence analysis of AGSI revealed strong homology with the family of small GTP-
binding proteins. AGS1 had previously been reported as Dex-Ras, a small G-protein up-
regulated by dexamethasone treatment (144). AGSI shared the PhosphatelMagnesium 
(PM) and guanine nucleotide ring binding domains (G) of other small G-proteins, but 
AGS 1 also contained unique sequences not detected in these related proteins. Cationic 
inserts near the C-terminus and modifications in the PM! region distinguish AGS 1 from 
other small G-proteins. The discovery of AGSI as a G-protein activator was significant 
since no small G-protein had been described to interact with or directly influence G-
protein signaling. Cismowski and co-workers demonstrated that AGS 1 could directly 
interact with Gia.2 subunits. Ribas contributed the finding that AGS 1 could increase 
GTPyS binding to G-proteins. Therefore AGSI is a G-protein GEF, supporting the 
hypothesis generated by the initial yeast data. AGSI activates a GrYi-mediated MAP 
kinase pathway in a pertussis toxin-sensitive manner, confinning the G-protein activating 
activity of AGS1 (143). Recently, AGS1 was isolated in a yeast two-hybrid screen with 
CAPON, a protein involved in nNOS signal transduction (145). Since NMDA-mediated 
activation of MAPK is pertussis toxin-sensitive, AGS1 may be involved in cross-talk 




AGS2 was isolated as a 770 nt eDNA encoding a previously described protein, 
tctex-l. Tctex-l was discovered in the mouse genome as a component of the t-complex, 
a cluster of genes that when mutated cause sterility and sperm defects (146). Tctex-l and 
its family member tctex-2 are light chains of the cytoplasmic motor protein dynein (147). 
Tctex-l binds to the intermediate chain of dynein and plays an unknown role in dynein 
function. AGS2 (tctex-l) was different from the other AGS proteins since it did not have 
a preference for the type of Gu subunits used in the yeast system. This was explained by 
interaction studies demonstrating binding of AGS2 to GJ3y subunits (115). The proposed 
mechanism of AGS2 in the yeast system was speculated to involve subunit dissociation. 
In this model, AGS2 would bind and liberate G~y subunits from Gn subunits without 
initiating nucleotide exchange. Gl3y free from the alpha subunit could then activate the 
pheromone response pathway despite the presence of AGS2. This mechanism was never 
confirmed outside of the yeast system. AGS2 or Tctex-l was isolated in several yeast 
two-hybrid screens. AGS2 was reported as a binding partner for Doc (148), Fyn (149) 
and interestingly for the C-terminus of rhodopsin (150). The rhodopsin report describes 
AGS2 as a facilitator of receptor trafficking within rod cells, classifying it as an 
accessory protein acting at the level of receptor. Whether Gl3y was involved in this 
process was not addressed. 
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AGS3 
AOS3 was discovered as a -1500 nucleotide cDNA encoding a novel protein. 
Sequence analysis at the nucleotide level indicated that AGS3 was homologous to a 
human cDNA, LON, and a mouse cDNA of unknown function, L23316. The C-terminal 
735 nt of LGN were isolated in a two-hybrid screen using Gia2 as bait (151). Aya 
Takesono demonstrated that the first 490 nucleotides of AGS3 retained activity in the 
yeast system. Before further characterizing AGS3, the protein product of AGS3 
conferring activity in the yeast system needed to be identified since two potential reading 
frames existed. At this point, I began my work with AGS3. Using site-directed 
mutagenesis, silent mutations were engineered into the AGS3 sequence (Figure 1.6A). 
Two frame one mutants, Silla (Q6-Stop) and Sillb (Q37-Stop), terminated frame one 
prematurely but kept frame two intact. Sil2, the frame two mutant (LIS-Stop), 
terminated frame two prematurely but kept frame one intact. When analyzed in the yeast 
system, the frame one mutants, but not the frame two mutant, lost activity (Figure 1.6B). 
Therefore the active product of AGS3 was a 74 amino acid protein encoded by frame one 
(255 bp). Analysis by immunblotting of protein products of wild type and frame two 
mutants confirmed that AGS3-framel was being expressed (Figure 1.6C). AGS3 was 
subcloned into a GST fusion protein vector. The GST-AGS3 fusion protein was 
produced in bacteria and purified. GST pull down assays performed with purified his 
tagged Gia,2 demonstrated that AGS3 interacted with Ga. subunits, and that this 
interaction was nucleotide-dependent (Figure 1.7) (115). 
BLAST analysis of the AGS3 protein product revealed a group of proteins that 
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Figure 1.6 Identification of the bioactive peptide encoded by AGS3. The original AGS3 cDNA isolated in the yeast screen was 
truncated at its 3' end to generate AGS3-490. The 3' truncation of AGS3 did not alter the bioactivity of the cDNA. Site-directed 
mutants were generated in the AGS3-490 construct. The frame 2 mutation T60A inserted a stop codon at L15 without altering the 
amino acid sequence of frame 1. For the frame 1 mutations, C46T and C148T, generated stop codons at Q6 or Q37 without altering 
the amino acid sequence of frame 2. Intact, truncated and site-directed mutants of AGS3 were evaluated in spot growth assays to 
identify the bioactive peptide sequence. Extracts were prepared from yeast transformants and evaluated for expression of the frame 
1 peptide by immunoblotting. Similar results were obtained in three experiments using different yeast extracts. 
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Figure 1.7 Interaction of AGS3 with Ga subunits. AGS3-CT and AGS2 were generated as GST-fusion proteins in bacteria and 
purified using a glutathione affinity matrix. GST -AGS3-CT and GST -AGS2 fusion proteins were incubated with G-protein 
subunits (Ga = 60-80 nM, fusion protein = ~300 nM, total volume = 250 ul) for 1 hr at 4°C in the presence of GDP (10 J.lM) or 
GTPyS (10 J.lM) plus MgCl2 (5 mM). Proteins were then adsorbed to glutathione matrix and retained G-protein subunits identified 
by immunoblotting following gel electrophoresis. Gia2 was generated in Sf9 cells as an amino terminal his6-tagged protein and 
detected on membrane transfers using anti -Xpress antisera (Invitrogen). Input refers to 20 J.lI of the incubation mixture. The 
results presented are representative of four separate experiments. The GST -AGS3 fusion protein was functionally similar to the 
original AGS3 isolate in terms of its ability to promote growth. 
were not detected by the nucleotide homology search included a predicted C. elegans 
protein, Pcp-2 (152), RGS12 (153), ROS14 (153) and Rap1-GAP (119). In addition to 
LGN, RGS12 and RGS14 were known to interact with Go; subunits, suggesting a 
conserved function for the shared motif, (153). Also of interest was that LON and 
L23316 contained four repeats of this motif whereas AGS3 contained amino acids 
corresponding to parts of the third and the complete fourth repeat of both proteins. These 
findings suggested that the AGS3 sequence isolated in the yeast system might represent 
the carboxy terminus of a larger protein. Using cDNA library screening and 5'RACE, a 2 
kb rat AGS3 cDNA was identified. These studies showed that the sequence isolated in 
the yeast system was the 74 amino acid carboxy terminus of a 650 amino acid protein. 
From this point I will refer to the 650 amino acid protein as AGS3, and to the 74 amino 
acid protein (M577-S650) as AGS-CT (AGS3- Carboxy Terminus). The focus of my 
dissertation will be the structural and functional characterization of AGS3. 
Sequence analysis of AGS3 revealed two distinct protein repeats separated by a 
100 amino acid linker (Figure 1.8). In the N-terminus, seven tetratricopeptide repeats 
(TPRs) were detected. TPRs are 34 amino acid motifs found in over 400 proteins (154). 
The TPR motif is highly degenerate with only eight of the thirty-four amino acids 
defining the repeat (154). TPRs, which are involved in protein-protein interactions, are 
generally found in tandem in copies ranging from 3 to 16 per protein. The presenc~ of 
TPRs in AGS3 did not suggest an interaction existed with any particular protein, but 
rather that this region was a site for protein-protein interactions. Four unclassified 
repeats were detected in the C-terminus. For reasons to be described later, we named this 
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Figure 1.8 Sequence alignment of AGS3 and related proteins. Full-length rat AGS3 (AAF08683) was aligned with the human 
LGN protein (AAB40385), the D. melanogaster PINS protein (AAF36967) and the C. elegans protein (CE) (AAA81387) by 
PILEUP (University of Wisconsin GCG program) and visual adjustment. Amino acid sequence similarity and identity are indicated 
below the four sequences by + or residue, respectively. The shaded and lined sequences represent the tetratricopeptide repeat motifs 
(TPR I-VII) and a repeated segment of amino acids (GPR I-IV). The amino terminus half of the AGS3 contains seven 
tetratricopeptide repeats (TPRs). With the exception of PINS, each protein contains four GPR repeats in their C-terminus. PINS 
contains three GPRs with highest homology to GPRs I, III, and IV of AGS3, LGN and CEo 
computer search as the GoLoco domain and were speculated to function as exchange 
factors for Giloa subunits in the D. melanogaster RGS protein, loco (130). The 
characterization of the GPR domain will be addressed at length in the following chapters. 
AGS3 shares similarity with many proteins through its TPR and/or GPR domains. 
Therefore, we classified AGS3 family members as those proteins with both N-terminal 
TPRs and C-terminal GPRs (Figure 1.9). At the time of the discovery of AGS3, very 
little was known about the function of AGS3 family members. My research was directed 
at uncovering the structure/function relationship of AGS3 and, in particular, how AGS3 
activated G-proteins. During the course of my study, the discovery of an AGS3 family 
member in Drosophila melanogaster offered initial clues about this protein family. 
v. ASSYMETRIC CELL DIVISION AND CELL POLARITY 
During the course of my research, PINS, the AGS3 homolog in Drosophila 
melanogaster, was functionally characterized. Each group reporting the discovery of 
PINS identified it as a required component of a polarity/asymmetry complex in 
Drosophila neuroblasts (155, 156). PINS, or Partner of Inscuteable, is associated with 
Inscuteable in the apical membranes of delaminating neuroblasts. PINS, Inscuteable and 
Bazooka are key interdependent components that set apica1/basal polarity and direct 
asymmetric cell division in neuroblasts. Asymmetric divisions give rise to basal ganglion 
mother cells (GMes) and to apical neuroblasts (157, 158). Neuroblasts can undergo 
additional rounds. of asymmetric divisions to form more GMCs. GMCs themselves 




Amino % sim. 
Acids toAGS3 
RatAGS3 650 
HumanAGS3 653 96 
HumanLGN 681 66 
D. mel. (PINS) 685 66 
AGS3-CE 111:.:. ~ I I III 579 42 
MouseLGN 210 82 
PigAGS3 145 95 
Bovine AGS3 342 95 
Fish AGS3 358 82 
Figure 1.9 AGS3 family members. AGS3 family members are proteins that contain both N-terminal TPRs (black) and C-
terminal GPRs (gray). AGS3 (AFI07723) has two family members in the human genome, LGN (U54999; 66% overall 
similarity) and Human AGS3 (AL543750, AI272212, 96% similarity). Human AGS3 is a predicted gene pieced together from 
Genbank and Celera genome project entries. Genbank entries also predict family members in mouse (AGS3 homolog L23316 
and others (-99%); LGN homolog AA543923 (-82%)), Japanese bony fish (AU168949), zebrafish (AI629073), puffer fish 
(AL338846), chick (AL584215), pig (BF442904, BF079490), cow (BF655288, BF750988), fruit fly (PINS or Rapsynoid; 
AF242203), nematode (AGS3-CE; U40409) and Xenopus (A W460360, BG234747) genomes. 
Ga. binding protein PINS with polarity/asymmetry proteins has some interesting 
implications for how the complex sets cell polarity. Recently, a flurry of reports has 
added new proteins to this complex. The reports also indicate that the 
polarity/asymmetry complex is highly conserved from C. elegans to D. melanogaster, 
and to some extent in mammals. In C. elegans, heterotrimeric G-proteins were recently 
shown to influence the proper rotation of the mitotic spindle in one- and two-cell 
embryos. If the polarity/asymmetry complex is conserved throughout evolution, then 
knowledge about PINS and its binding partners will help to define the function of AGS3. 
A. DETERMINANTS OF CELL POLARITY AND ASSYMETRIC DIVISION 
A fundamental question in the field of developmental biology is how asymmetric 
cell divisions occur. Asymmetric division of a precursor cell generates two distinct cells, 
leading to specialization and eventually differentiation. For asymmetric divisions to 
occur, proteins or RNA must themselves be asymmetrically localized. When cell 
divisions occur, the cytoskeleton must respond to cues from the opposing poles to 
generate daughter cells of different sizes. The mitotic spindle must be properly oriented 
to properly place asymmetric factors in the appropriate daughter cell. Model organisms 
such as the fruit fly Drosophila melanogaster and the nematode Caenorhabditus elegans 
have led the way in the study of development and therefore asymmetric cell divisions. 
Since PINS is a determinant of cell polarity in the developing fruit fly nervous system, 




Bazooka was isolated as a gene required for maintaining polarized blastoderm 
epithelium (159). During neuroblast formation, a cell migrates out from the 
neuroepithelial sheet to the basal surface of the neuroepithelium. As the cell leaves the 
epithelial sheet, it buds out on the basal side. This process is known as delamination and 
is illustrated in Figure 1.10. Bazooka is apically localized in the neuroepithelial layer 
and maintains this localization as the· neuroblast delaminates. Subsequent reports 
revealed that Bazooka recruits Inscuteable to apical membranes of delaminating 
neuroblasts (160-162). Bazooka therefore was designated an apical cue for Inscuteable 
localization, suggesting that Bazooka acts upstream of Inscuteable (162). However, once 
the neuroblast has delaminated, Bazooka localization is disrupted in Inscuteable and 
PINS mutants (155, 156). 
One purpose of maintaining cell polarity is to direct the proper orientation of the 
mitotic spindle. In epithelial cell layers, cell division occurs in the plane of the sheet. 
When neuroblasts delaminate, the mitotic spindle must be rotated by 90 degrees relative 
to the axis of division of the epithelial sheet (157, 158). Cell division of neuroblasts 
occurs along the apicallbasal axis. Bazooka mutants fail to rotate the mitotic spindle to 
the proper orientation (160). Whether this effect is directly attributable to Bazooka, or 
whether Bazooka acts on the mitotic spindle through proteins such as Inscuteable and 
PINS, is unknown. Since Bazooka is present in both epithelial cells and in neuroblasts, 
some have speculated that Bazooka sets polarity, but does not directly influence mitotic 
























Figure 1.10 Neuroblast delamination and asymmetric division . . The left panel depicts the localization of the BazookalPar-
6/aPKC complex (blue), inscuteable (yellow) and PINS (red) during delamination and cell division. As neuroblasts delaminate 
out of the epithelial layer their apical membrane stays in contact with the basal surface of the epithelium. Before delamination the 
Bazooka complex is apically localized whereas INSC and PINS are not. During early stages of delamination, inscuteable and 
PINS are localized to the apical crescent. After the neuroblast has delaminated all three proteIns are interdependent . for proper 
localizqtion to the apical crescent. In late stages of cell division, the amount of inscuteable and ' PINS at the apical .membrane is. 
diminished. .Once the ganglion mother cell has divided, the neuroblast can undergo more asymmetric divisions. The right panel 
shows the corresponding orientation of the mitotic spindle during those processes. 
Inscuteable 
Inscuteable was discovered as a gene that was up-regulated during periods of 
neuroblast differentiation and migration (163). Analysis of Inscuteable expression and 
sequence suggested that the protein was a putative cytoskeletal adapter. Five ankyrin-
like repeats were detected, supporting this hypothesis. In the same year, Inscuteable was 
implicated as a key determinant of asymmetric divisions in Drosophila neuroblasts (164). 
Inscuteable mutants failed to properly orient the mitotic spindle during neuroblast 
delamination. When Inscuteable was ectopically expressed in epithelial cells, the mitotic 
spindle was re-oriented (164). Two proteins, Numb and Propero, normally localized to 
basal membranes during delamination, were distributed throughout the cell in insc-
neuroblasts (164). Numb is a PTB protein possibly involved in setting basal polarity and 
inhibiting Notch signaling (165). Pro spero , a homeo-domain containing transcription 
factor, likely directs neuron-specific expression (165-167). Another protein, Miranda, 
was also shown to be directed to basal crescents by Inscuteable (168-170). Miranda is an 
adapter protein, linking Inscuteable to the localization of Prospero and Staufen (169). 
Although Inscuteable mutants displayed mislocalization of asymmetrically distributed 
proteins, there was no effect on cell size (171). 
Bazooka provides the apical cue for Inscuteable localization (161, 162). 
Inscuteable was not detected in the neuroepithelium, but was present during, or just after, 
delamination (164, 172). Since Bazooka mutantions result in a cytosolic distribution of 
Inscuteable, translocation of Inscuteable presumably initiates the basal localization of 
downstream factors (162). However, Inscuteable knockouts also display incorrect 
44 
localization of Bazooka in neuroblasts (161). Some disagreement exists about the precise 
relationship between Inscuteable and Bazooka. Generally Bazooka is thought to playa 
polarity-setting role. Inscuteable, once at the membrane, appears to help in maintaining 
polarity while directing the localization of several proteins. 
Inscuteable is unique among polarity/asymmetry proteins since it does not have 
any counterpart in the C. elegans or mammalian genomes. Sequence analysis detects five 
regions with weak homology to ankyrin repeats; the rest of the sequence has no 
homology to known proteins (163). Using deletion analysis, Knoblich localized a region 
of Inscuteable capable of directing protein localization and maintaining cell polarity 
(172). This region, which contained the five ankyrin repeats, was used to search for 
Inscuteable binding partners. 
PINS, partner of Inscuteable 
Using a two-hybrid screen with the ankyrin repeat region of Inscuteable as bait 
the AGS3 homolog Partner of Inscuteable (PINS) was discovered (156). Another group 
found a 70-kDa protein, later identified as PINS, in a preparative immunoprecipitation 
using the same asymmetry domain of Inscuteable (ISS). Two-hybrid screening with the 
Drosophila Gin as bait yielded the discovery of "rapsynoid" (pINS) by a third group 
(173). PINS was found in delaminated neuroblast apical crescents, consistent with the 
distribution of Inscuteable and Bazooka. The phenotype of PINS mutants essentially 
mimicked that of Inscuteable mutants. Loss of PINS function resulted in mislocalization 
of Inscuteable and Bazooka during cell division. Bazooka localization was only affected 
after the neuroblast delaminated (156). PINS mutants displayed the same spindle rotation 
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defect found in Inscuteable mutants (155, 156). Proteins downstream of Inscuteable, 
such as Miranda and PON, were mislocalized in PINS mutants (156). Yu and co-workers 
noted that daughter neurons of GMCs in pins- animals were symmetric, as evidenced by 
expression of Eve (156). In wild type animals Eve expression is limited to one daughter 
neuron (174). Parmentier discovered that pins- neuroblasts divided symmetrically (173). 
The proper hierarchy of polarity/asymmetry proteins is still debatable. Both groups 
contend that PINS acts downstream of Inscuteable based on genetic and expression 
studies. To that hypothesis, Parmentier adds the possibility that PINS and Inscuteable 
may simultaneously arrive at apical membranes to elicit asymmetric division and 
asymmetric direction of proteins, respectively, but that they are independently required to 
maintain cell polarity. 
Two of the three groups studying PINS demonstrated that PINS interacts with 
Giloa subunits (155, 173). Schaefer and co-workers localized the Gu binding domain to 
the C-terminus of PINS, a region containing three GPRs. Both groups restricted the 
Inscuteable-binding domain on PINS to the N-terminal TPRs (155, 156). The region of 
Inscuteable responsible for PINS interactions is confined to the asymmetry domain or 
ankyrin repeat domain. Despite the preparative immunoprecipitation used to isolate 
AGS3, all demonstrations of Gia interacting with polarity/asymmetry components were 
performed in vitro. Localization of heterotrimeric G-proteins during neuroblast 
delamination was not evaluated. Both groups presented PINS as a mosaic protein linking 
G-proteins to the polarity/asymmetry complex. Each group also agreed that PINS, 
Inscuteable and Bazooka become interdependent once neuroblasts enter prophase. Their 
findings imply that Inscuteable has a dual function: a) directing basally localized proteins 
46 
and b) recruiting PINS to apical membranes. If PINS requires only Inscuteable to get to 
apical membranes, then some interesting issues arise. Inscuteable has no homologs in 
any other organism whose genome has been completed (C. elegans, H sapiens, etc.), nor 
does Inscuteable share homology with any sequences yet entered in the Genbank 
database. If PINS homologs play similar roles in their respective organisms, then they 
may utilize Inscuteable-independent mechanisms to arrive at apical membranes (173). 
The mechanism by which PINS arrives at the membrane is still poorly 
understood. PINS is detected in the cytosol of neuro-epithelial cells, and arrives at 
neuroblast apical crescent during prophase, after the neuroblast delaminates (155). 
Bazooka is expressed at apical membranes before, during and after delamination. 
Inscuteable is not detected in the neuroepithelium (161, 162). Inscuteable expression is 
believed to be up-regulated at the time of delamination (163). PINS distribution in 
Inscuteable mutants is cytosolic, suggesting that translocation of PINS to the membrane 
is triggered by expression of Inscuteable (156). Ectopic expression of Inscuteable in the 
neuroepithelium leads to mitotic spindle rotation and asymmetric division (163), 
supporting this hypothesis. 
B. POLARITY/ASYMMETRY COMPLEX 
Very soon after PINS was discovered, several more proteins were added to the 
polarity/asymmetry complex. The new information has revealed a striking similarity 
between D. melanogaster neuroblast division and divisions of the on- cell stage in C. 
elegans. Some of the components play roles in setting mammalian epithelial polarity. 
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Figure 1.11 depicts the polarity/asymmetry complex, and Table 1.3 summarizes polarity 
and asymmetry determinants found in C. elegans, D. melanogaster and M. musculus. 
BazookalaPKClPar-6 
Bazooka transfers apical polarity from neuroepithelial cells to neuroblasts. 
Recent findings suggest that two additional D. melanogaster proteins, atypical Protein 
Kinase C (DaPKC) and DmPar-6, co-localize with Bazooka before, during and after 
neuroblast delamination (175, 176). All three proteins are found in apical membranes of 
epithelial cells and neuroblasts, where they are interdependent for apical localization 
(158). The complex at apical crescents is maintained from late interphase until late 
anaphase .(157). When the neuroblast starts an additional round of division, the complex 
is re-established at the apical pole. Bazooka homologs in C. elegans (par-3) and M. 
musculus (ASIP) have been described. Par-3 is one of six partitioning defect genes 
identified as factors in the asymmetric division of one-cell embryos (177). Par-3 and Par-
6 are anteriorly localized in the one-cell embryo (177,178). Some Par proteins, such as 
Par-4, are not anteriorly localized. Par-4 acts by affecting the localization of Par-3 and 
Par-6 (179). The C. elegans homolog of DaPKe, PKC3, is also required for proper 
asymmetric divisions of one-cell C. elegans embryos (180). As observed in Drosophila 
neuroblasts, all three proteins are interdependent for proper polarity and division (179). 
ASIP, atypical PKC isoform-specific interacting protein, was identified as a component 
of tight junctions that interacted with atypical Protein Kinase C lambda (A) and zeta (~) 
(181). Also present in this complex is the mammalian homolog of Par-6, mPar-6 (182, 





Figure 1.11 Polarity/asymmetry complex. Members of the polarity /complex from three 
species · are represented . in corresponding colors. Top- C. elegans, Middle- D. f!lel(,lnogaster, 
Bottom: M. musculus. Proteins with bold borders have be'en showp. experimentally to function 
in asymmetric divisions and/or maintaining polarity. In . different species, the ' complex is 
detected in different · stages of development and/or cell type.' C. elegans- one cell stage; D. 
melanogaster- neuroblast; M. musculus- epithelial cell tight junctions. Interactions between 
proteins are noted by overlaps . . Question marks indicate that no homolog is detected for that 
species in available databases. 
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c. elegans D. melanogaster M. musculus Function 
Par-3 Bazooka ASIP Sets & maintains apical polarity 
Par-6 dPar-6 mPar-6 Sets & maintains apical polarity 
PKC3 aPKC PKCIJ~ Sets & maintains apical polarity 
CDC42 CDC42 CDC42 Sets & maintains apical polarity 
No homolog in 
Inscuteable 
No homolog in Directs basal localization; Rotates 
genome genome mitotic spindle; Recruits PINS 
AGS3-CE PINS AGS3 
Similar to Insc; Maintains apical 
polarity; Recruits Giloa 
Recruited to apical complex 
Gia Gia Gia (Dm); Sets spindle in one cell 
stage (Ce) 
Gp G~ G~ Directs spindle rotation in one 
cell stage (Ce) 
Table 1.3 Polarity/Asymmetry Determinants. Corresponding proteins from C. elegans, 
D. melanogaster and M. musculus, as well as the known functions of those proteins, are 
listed. Bold indicates experimental evidence for involvement in aspects of cell polarity 
and/or asymmetric division in the following contexts: C. elegans- one-cell stage, D. 
melanogaster- neuroblast delamination, M. musculus- epithelial cell tight junctions. 
melanogaster- neuroblast delamination, M. musculus- epithelial cell tight junctions. 
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do not interact with each other (181, 182). Another component identified in epithelial 
cell tight junctions is CDC-42. CDC-42, a small G-protein implicated in actin regulation, 
binds to and co-localizes with mPar-6 (182-185). CDC-42 has homologs in both the fly 
and worm, but neither has been linked to cell polarity/asymmetric division (186). 
InscuteableIPINS 
" Inscuteable and PINS join the BazookalaPKClPar-6 trio during or just after 
neuroblast delamination. Thus, the Bazooka complex sets the apical pole in the 
neuroepithelium to which Inscuteable and PINS localize once the neuroblast forms. Once 
InscuteablelPINS join the other proteins at the apical crescent, they are required for 
maintenance of the complex (156, 158). Mammalian and insect epithelial cells 
containing the Bazooka complex do not divide along the apical/basolateral axis. Ectopic 
expression of Inscuteable in epithelial cells causes spindle rotation, while ectopic 
expression of PINS in epithelial cells has no effect (156-158). These findings suggest 
that Incuteable acts upstream of PINS. While Inscuteable has no homologs in any other 
species, PINS is the fruit fly representative of the AGS3 family, which has a predicted 
family member in C. elegans. If AGS3 function is conserved throughout evolution, then 
AGS3IPINS proteins must require Inscuteable-independent mechanisms to arrive at 
apical membranes. 
C. HETEROTRIMERIC G-PROTEINS IN POLARITY/ASYMMETRY 
Heterotrimeric G-proteins are linked to apical membranes by the GPR repeats of 
PINS (155). Whether a similar mechanism occurs in C. elegans or in mammalian cells 
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has yet to be determined. Initial studies of G-protein knockouts in the nematode did not 
identify any embryonic phenotype, possibly because the maternal contribution of G-
proteins was overlooked (187). Knocking out both the maternal and daughter sources of 
GJ3 subunit resulted in early embryonic lethality characterized by abnormal mitotic 
spindle orientation (188). Earlier this year, both Ga and GJ3 subunits in C. elegans were 
implicated in control of mitotic spindle rotation of the one- and two-cell zygotes. Using a 
series of RNAi (RNA interference) and knockout strains, the functional roles of Ga and 
GJ3 subunits in early embryonic cell division were further characterized (55). G(3 RNAi 
worms displayed random axis setting at the one-cell stage, suggesting that G(3 directly 
influenced the mitotic spindle rotation. A double knockout of early-expressed Go. 
subunits, Goo.l and Gpal6, resulted in a phenotye consistent with G(3 overexpression. 
The centrosomes did not migrate to opposite poles before the nuclear envelope broke 
down. Also, the Ga knockout zygotes did not divide asymmetrically to form PI and AB 
cells. In some of the resulting AB cells, the nuclei were misplaced. G(3 was not localized 
to the membrane in Go. mutants, supporting the hypothesis that Go. depletion leads to 
enhanced GJ3 function on the cytoskeleton. 
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CHAPTER 2 
FOCUS OF RESEARCH AND SPECIFIC AIMS 
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As the core components of G-protein signaling became more completely 
understood, factors modifying the transfer of signal from receptor to G-protein to effector 
began to be appreciated. These factors provide specificity to G-protein signaling that 
could not be achieved by the core components of receptor, G-protein and effector. 
Efforts by our laboratory to define a signal transduction complex ultimately led to the 
isolation of a putative G-protein activator, AGS3. Biochemical evidence indicated that a 
factor in NG-108 membranes could activate G-proteins independent of receptor 
stimulation. As an alternative to unsuccessful protein purification schemes, a functional 
screen was employed to isolate proteins capable of activating G-proteins independent of 
receptor stimulation. Screening of a NO-108 cDNA library in the yeast expression 
cloning system resulted in the isolation of a novel protein, AGS3. As part of our 
laboratory's goal to identify novel accessory proteins to G-protein, I was charged with 
characterizing the G-protein activator, AGS3. 
At the time when I entered the lab, AGS3 and its family members were not 
completely characterized with respect to function. An AGS3 family member in humans, 
LGN, was shown to interact with G-proteins in a yeast two-hybrid screen (151). 
Common to both AGS3 and LGN are four uncharacterized repeats in the C-terminus. 
The fragment of AGS3 isolated in the yeast system contained one partial and one 
complete repeat. These domains were also present in two members of the RGS family 
suggesting that AGS3 contained a novel Go. interaction domain. Since AGS3 was 
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isolated in a screen designed to select for G-protein activators, we developed our first 
hypothesis about AGS3. This hypothesis is that AGS3 is a G-protein regulator, a 
protein that can 1) influence the transfer of signal from receptor to G-protein 
and/or 2) influence the activation state of G-proteins independent of receptor 
stimulation. Because AGS3 was·a novel protein and a possible G-protein regulator, my 
initial research focused upon the interactions of AGS3 with G-proteins. 
Another aspect of AGS3 function revolves around the distinct protein repeat 
structure. AGS3 contains seven tandem N-tenninal TPRs, a protein motif found in over 
400 proteins implicated in protein-protein interactions (154). While the C-tenninus of 
AGS3 appeared to bind G-proteins, the AOS3-TPR region did not have an apparent 
function. TPRs are such degenerate motifs that very little can be gleaned from their 
presence alone. Our best clue came from a protein named rapsyn, which contains similar 
number and spacing of TPRs in its N-terminus (189). Rapsyn is localized to post-
synaptic membranes via its TPR domain. If the TPRs of AGS3 have a similar function, 
they may localize AGS3 to particular subcellular domains. Alternatively, the TPR 
domain might regulate the function of the C-terminus. Our hypothesis concerning the 
AGS3 N-terminus is as follows: The AGS3 TPR domain binding partner(s) regulate 
the localization and/or function of AGS3. Our goal was to utilize a yeast two-hybrid 
screen with the TPR domain as bait to identify potential binding partners. With insight 
and advise from Tim McQuinn and Mary Cismowski, we settled upon using a yeast strain 
pre-transformed with a rat brain eDNA library as our source of prey sequences. During 
the course of our research, we initiated another screen using a mouse 11 day-old 
embryonic library. 
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At the inception of my dissertation research, very little was known about the 
function of AGS3 family members. Genbank BLAST searches of the C. elegans genome 
turned up an AGS3 homolog that I will refer to as AGS3-CE (cosmid name F32A6.4). 
AGS3-CE has five predicted N-terminal TPRs and four C-terminal GPRs~ with an overall 
homology of 42% with AGS3. As an initial approach to define the function of AGS3, we 
sought to characterize the function of AGS3-CE. The completion of the C. elegans 
genome and the depth of knowledge about cell fate in this organism facilitated analysis of 
gene function. Recent technological advances have allowed for the easy generation of 
knockout animals in the nematode. Fire developed the RNA-interference method (RNAi) 
in 1998 to generate knockout animals (190). He demonstrated that double-stranded RNA 
(dsRNA) injected into parental wonns could selectively suppress expression of the 
encoded protein in Fl worms. Operating under the hypothesis that AGS3 influences G-
protein function in the intact animal, we sought to initiate experiments with AGS3-CE. 
These studies were initiated in collaboration with Dr. Guy Benian at Emory University. 
My overall goal was to structurally and functionally characterize the Activator of 
G-protein Signaling 3, AGS3. Since AGS3 was a founding member of a novel protein 
family, I had the unique opportunity to characterize a new class of G-protein regulators. 
Armed with a sequence and a link to G-protein function, I began my efforts to ultimately 
learn the role of AGS3 function. To accomplish my goals I developed the following 
specific aims: 
Specific Aim1: Identify and characterize the domains of AGS3 involved in G-
protein subunit interactions 
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A) Does AGS3 interact with Ga subunits? 
B) Which domains of AGS3 are involved in G-protein interactions? 
C) Characterization of the AGS3 domains responsible for Ga interactions. 
D) Is the GPR domain required for Ga interactions? 
Specific Aim 2: Define the specificity of the AGS3-Ga interaction. 
A) Does AGS3 interact with specific Ga subtypes? 
B) Does AGS3 interact with specific members of the Giloa family? 
C) Does AGS3 interact with multiple Ga subunits? 
Specific Aim 3: Define the mechanism by which AGS3 activates G-protein signaling. 
A) Can AGS3 influence G-protein subunit interactions? 
B) How does AGS3 influence the activation state of G-proteins? 
C) Can AGS3 influence the transfer of signal from receptor to G-proteins? 
Specific Aim 4: Identify binding partners of the AGS3-TPR region. 
A) Screen a mammalian cDNA library for potential TPR binding partners. 
B) Identify and characterize candidate positive clones. 
C) Verify protein-protein interactions outside of the yeast screen. 
Specific Aim 5: Define the function of AGS3 in the intact organism. 
A) Analyze the expression pattern of the C. elegans homolog of AGS3. 
B) Characterize the knockout phenotype of AGS3 in C. elegans. 
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CHAPTER 3 




[35S]GTPyS (1250 Ci/mmol) was purchased from DupontINEN (Boston, MA). 
Tissue culture supplies were obtained from JRH Bioscience (Lenexa, KS). Acryl amide , 
bis-acrylamide, protein assay kits and sodium dodecyl sulfate were purchased from Bio-
Rad (Hercules, CA). Ecoscint A was purchased from National Diagnostics (Manville, 
NJ). Guanosine diphosphate, guanosine triphosphate, and Thesit (polyoxyethylene-9-
lauryl ether) were obtained from Boehringer-Mannheim (Indianapolis, IN). 
Polyvinylidene difluoride membranes were obtained from Pall Gelman Sciences (Ann 
Arbor, MI). Gammabind G Sepharose was obtained from Amersham-Pharmacia 
(piscataway, NJ) and nitrocellulose BASS filters were purchased from Schleicher and 
Shuell (Keene, NH). Purified bovine brain G-protein and antisera to the carboxyl-
terminal 10 amino acids of G~1," which recognizes G~1-4, were kindly provided by Dr. 
John Hildebrandt (Department of Pharmacology, Medical University of South Carolina) 
(191, 192). Gia.1-3 and Goa were purified from Sf9 insect cells infected with 
recombinant virus as described (193) and kindly provided by Dr. Stephen Graber (West 
Virginia University School of Medicine). Gsa. and Gqa., similarly expressed in Sf9 insect 
cells, were kindly provided by Dr. Elliott Ross (University of Texas Southwestern 
Medical Center) (194). Purified Gta and Gt~y were kindly provided by Dr. Heidi Hamm 
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(Northwestern University Medical School) (195). Polyclonal Gia3 antisera generated 
against the carboxyl-terminal 10 amino acids was kindly provided by Dr. Thomas W. 
Gettys (Department of Medicine, Medical University of South Carolina) (196). Purified 
GA antibody, which selectively recognizes Gi/Goa, was kindly provided by Drs. Paul 
Goldsmith, Andrew Shenkar and Allen Spiegel (197). All other materials were obtained 
as described elsewhere (115, 198). 
Materials for Saccharomyces cerevisiae two-hybrid screening 
Yeast strains pre-transformed with prey eDNA libraries, Anti c-Myc monoclonal 
antisera and KC-8 chemically competent cells were obtained from Clontech. Bait vector 
pGBKTI and yeast strains Y187 and AHI09 were kindly provided by Dr. Tim McQuinn 
(Medical University of South Carolina). Amino acids and J3-mercaptoethanolwere 
obtained from Sigma. Technical agar was purchased from Difco. All other media 
reagents and supplies were obtained from Fischer. The pGEX5X2 vector, BL-21 
competent cells and Glutathione Sepharose 4B were purchased from Pharmacia Biotech. 
PVDF membranes were obtained from Pall Gelman Sciences (Ann Arbor, MI). X-Gal 
was bought from Boehringer Manheim. All other materials were obtained as described 
elsewhere (198). 
c. elegans materials 
C. elegans genomic DNA and vector pD96.04 were kindly provided by Dr. Guy 
Benian (Emory University). T7 and T3 mRNA synthesis kits were purchased from 
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Gibco. High Fidelity PCR reagents were obtained from Boehringer. All other C. elegans 
reagents were provided by Dr. Benian's laboratory. 
METHODS 
General methods 
Generation of AGS3 subdomains AGS3 subdomains were generated as glutathione fusion 
proteins by polymerase chain reaction (PCR) using the full length cDNA of AGS3 as a 
template. Primers were designed to add BamHI and BeoRI sites to the 5' and 3' ends, 
respectively, of AGS3 subdomains to fuse the AGS3 open reading frame with the reading 
frame of glutathione-S-transferase contained in the pGEX4Tl vector. The PCR reactions 
were generally performed using 250 nM primers and 125 pM template DNA in a total 
volume of 50 JJL. Cycles were 1 x 3 minutes at 94°C; 30 x 1.5 minutes at 94 °c, 1 
minute at 60°C, and 2 minutes at 72 °C; 1 x 10 minutes at 72°C. Primers used to 










3'- GGGAA TTCTT AGCTGGCACCTGGCGGACA. 
GPRI (I463-E501) 
5'- CGGGATCCACCATGGCCCCGTCCTCT 









3'- GGGAA TTCTTAGCTGGCACCTGGCGGACA. 
GST fusion protein purification Overnight cultures of transformed BL-21 bacteria were 
diluted (1:50) into fresh 2XYTA media (lL: 16 g Tryptone, 10 g Yesat Extract, 5 g NaCI, 
pH 7.0) and incubated with 250 rpm shaking at 37°C for 2 hours. After inducing protein 
expression by the addition of 100 mM !PTG (1000X), the culture was incubated at 30°C 
for an additional 3 hours. Pellets from 5,000 x g spins at 4 °c were resuspended (50 m1 
FP bufferlL culture volume) in Fusion Protein buffer (10 mM Na2HP04, 1.8 mM 
KH2P04, 2.7 mM KCI, 140 mM NaCI, 1 mM EDTA plus protease inhibitors) and 
sonicated using a Branson Sonifier 250 (output setting 2, constant sonication) for 30 
seconds. Lysates from 12,000 x g spins were incubated with 50% Glutahtione Sepharose 
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4B slurry in FP buffer (2 mL slurry/L culture volume) for 30 minutes at 4°C. Packed 
resins from 1,000 x g spins were washed sequentially with 10 mL of FP buffer, 10 mL of 
FP buffer plus 250 mM NaCI and 10 mL of FP buffer plus 500 mM NaCl. Washed resins 
were transferred to fresh 1.5 m1 tubes using FP buffer. Fusion protein was eluted from 
packed resins by incubation with elution buffer (10 mM reduced Glutathione in 50 mM 
Tris pH 8.0) overnight at 4 °c (2: 1, elution buffer to packed resin). After removal of the 
first elution fraction, an additional elution was performed as described except at room 
temperature for two hours. Eluted fractions were concentrated and desalted by 
ultracentrifugation using Centricon molecular weight cutoff 3 kDa filter tubes. After the 
fractions were spun at 6,000 x g for one hour at 4°C, the concentrated protein was 
washed with 3 applications of 300 f..tl of 20 mM Tris pH7.5. Between each wash, the 
concentrate was spun at 6,000 x g for one hour at 4°C. Concentrated fusion proteins 
were evaluated by Bio-Rad protein assays and by coomassie blue staining of SDS-PAGE 
gels. 
Preparation of celVtissue lysates DDTI-MF2 cells were grown as previously described 
(87). Rat brain was homogenized in 3 ml buffer/gram tissue of lysis buffer (50 mM Tris 
pH 8.0,150 mM NaCI, 5 mM EDTA, 1% NP-40) and then incubated at 4 °c for 2 hours 
with rotation. Confluent 100 rom dishes of cells were washed with cell washing solution 
(137 mM NaCI, 2.6 mM KCI, 1.8 mM KH2P04, 10 mM Na2HP04) and then resuspended 
in 1 mlIdish of lysis buffer by homogenization. Cell homogenates were incubated for one 
hour on ice. Tissue/cell homogenates were centrifuged at 27,000 x g for 30 minutes. 
Supernatants were collected and spun at 100,000 x g for one hour to generate a detergent-
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soluble fraction. The supernatant was immediately processed. for immunoblotting or 
immunoprecipitation. Protein concentrations were determined by a Bio-Rad protein 
assay. 
Protein interaction assays The interaction of AGS3 with G-proteins was assessed by both 
co-immunoprecipitation and protein interaction experiments using tissue/cell lysates or 
purified G-proteins. For immunoprecipitation from mammalian cells, cell/tissue lysates 
(1-3 mg of protein in .5 -1 ml) were pre-cleared by rotating incubation with Gammabind 
G Sepharose (12.5 ~l packed resin equilibrated in lysis buffer) for 30 min at 4°C. 
Following centrifugation, Gia3 antisera (1 :250 dilution) was added to pre-cleared lysates 
and incubation continued overnight at 4°C. Protein complexes were captured by adding 
Gammabind G Sepharose (12.5 J..lI packed volume) and continuing the incubation for 30 
min at 4°C. The mixture was then microfuged at 4°C and the pellets washed (3 x 500 ~l 
of incubation buffer) and resuspended in 2 x Laernmli buffer. Resuspended samples were 
placed in a boiling water bath for 5 min and microfuged for 10 min prior to loading on 
denaturing 10% polyacrylamide gels. Proteins were transferred to PVDF membranes for 
immunoblotting. 
For analysis of the interaction of AGS3-GPR with multiple G-protein subunits, 
Gia.2 (200 nM) was incubated with Gia3 (50 nM) in the presence or absence of the 
AGS3-GPR GST-fusion protein (250 nM) in 250 at buffer A (20 mM Tris pH 7.5, 70 
mM NaCI, 1 mM dithiothreitol, 0.6 mM EDTA, 0.01 % Thesit) for one hour at 4°C. Gia.3 
antisera (1 : 500) was added and the incubation was continued for 3 hours at 4°C. Protein 
complexes were isolated and evaluated by immunoblotting as described above. 
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Protein interaction assays using purified G-protein subunits were conducted as 
previously described (198). All purified G-proteins used in these studies were isolated in 
the GDP-bound form. Unless indicated otherwise, all G-protein interaction assays 
contained 10 JlM GOP. The AGS3-GST fusion proteins were expressed in and purified 
from bacteria using a glutathione affinity matrix. The AGS3-GST fusion proteins were 
eluted from the matrix with glutathione and desalted by centrifugation (Centricon YM-3; 
Millipore - Bedford, MA). For interaction assays with cell/tissue lysates, the AGS3-GST 
fusion protein (100-300 nM) was incubated with purified G-protein (50-100 nM) or 
cell/tissue lysate (-4 mg proteinlml) for 1 hr at 24°C in a total volume of 250 f.1L. 12.5 
J.11 of packed glutathione-sepharose slurry was added and the mixture rotated at 4 °C for 
20 min, after which the affinity matrix was pelleted and washed three times with 500 f.11 
of incubation buffer. Proteins retained on the matrix were solubilized in 2 x Laemmli 
loading buffer and separated by electrophoresis on denaturing, 10% polyacrylamide gels. 
Proteins were transferred to PVDF membranes for immunoblotting. Each blot was 
checked by amido-black staining to verify equal loading of fusion proteins. 
PVDF membrane transfers After applying samples to SOS polyacrylamide gel 
electrophoresis, protein was transferred to PVDF membrane as described below. After 
electrophoresis SOS gels were placed in ice-cold transfer buffer (20% methanol, mM Tris 
and mM Glycine) and allowed to soak for 5-10 minutes. A transfer sandwich was made 
onto the base of a Bio-Rad semi-Dry transfer apparatus from bottom to top: whatman 
paper (soaked in transfer buffer), PVDF membrane (soaked in methanol), SDS gel, 
whatman paper (soaked in transfer buffer). Transfer onto PVDF membranes occurred 
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using constant amperage (.4-.5 Amps) with variable volts «=20 V). Time of transfer 
ranged from 60-100 minutes depending upon membrane size. Membranes were 
immediately processed for immunoblotting. 
Immunoblotting PVOF membrane transfers were blocked in blocking solution (7% milk, 
0.2% tween, 20 mM Tris pH 7.6, 150 mM NaCI) for one hour at room temperature with 
gentle rocking. Membranes were washed twice for 15 minutes each in wash solution 
(0.2% tween, 20 mM Tris pH 7.6, 150 mM NaCl). Membranes were then exposed to 
primary antibody diluted in wash solution for one hour. After two 15 minute washes in 
wash solution, conjugated secondary antibody of the appropriate dilution and species 
(diluted in wash solution) was applied to membranes for 20-30 minutes. Membranes 
were then washed twice for 15 minutes each and prepared for chemmiluminescence. 
Washed membranes were blotted dry and added to ECL reagent (NEN). Membranes 
shaken in ECL for one minute were blotted dry and exposed to film. For storage, 
membranes were washed for ten minutes to remove ECL and placed in plastic wrap and 
kept at 4 oC. For further re-probing, membranes were washed for ten minutes and then 
subjected to the stripping procedure. 
Nucleotide binding assays.. Nucleotide binding assays were conducted by a modification 
of a previously described techniques (141, 199). G-proteins (100 nM) were preincubated 
with varying amounts of AGS3 subdomain proteins or GST controls for 15 minutes at 
24°C (binding buffer = 50 mM Hepes-HCI pH 7.5, 1 mM EDTA, 2 mM MgClz, 1 mM 
dithiothreitol, 50 J.lM adenosine triphosphate, 10 J,lglml bovine serum albumin) prior to 
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addition of 0.5-1 f,LM GTPyS (4.0 x 104 dpm/pmol); the final incubation volume was 50 
J.1L. Samples were incubated with GTPyS at 24°C for 30 min. Incubated reactions were 
terminated by rapid filtration through nitrocellulose filters (S&S BA85) with 4 x 4 ml 
washes of stop buffer (50 mM Tris-Hel, 5 mM MgCI2, 1 mM "EDTA, pH 7.4, 4°C). 
Radioactivity bound to the filters was detennined by liquid scintillation counting. 
High affinity agonist binding- Sf9 cell membranes expressing 5-HTIA receptors were 
reconstituted with GaJ3y, and high affinity agonist binding was measured with 3H-5-HT 
as described previously (200). Membrane aliquots (100 J.1g of membrane protein, 85 nM 
receptor) were preincubated for 15 min at 25°C with G-proteins (2125 nM GaJ3y) with 
or without AGS3 fusion proteins in a total volume of 17 J...lI (reconstitution buffer, 5 mM 
NaHEPES, 100 mM NaCI, 5 mM MgCI2, 1 mM EDTA, 500 nM GDP, 0.04% CHAPS, 
pH 7.5). The reconstitution mixtures were then diluted 10-fold with binding buffer (50 
mM Tris-HCI, 5 mM MgCI2, 0.5 mM EDTA, pH 7.5), and 50 J.1I were added to binding 
tubes (total volume = 150 J.11) containing 2 nM 3H-5-HT. The final concentrations of 
receptor, G-protein, and fusion protein in the binding tubes were 2.8 nM, 70.8 nM, and 
13 J,1M, respectively. Nonspecific binding was determined in the presence of 100 J.LM 5-
HT. Binding reactions were incubated at 25°C for 1.5 h and terminated by filtration over 
Whatman GF/C FP200 filters using a Brandel cell harvester. The filters were rinsed thrice 
with 4 ml of ice-cold washing buffer (50 mM Tris-CI, 5 mM MgCI2, 0.5 mM EDTA, 
0.01 % sodium azide, pH 7.5, at 4°C), placed in 4.5 ml of CytoScint, and counted to 
constant error in a scintillation counter. 
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Stripping and re-probing of PVDF membranes- For reprobing of membrane transfers, the 
membranes were washed with immunoblot wash buffer (20 mM Tris-HCI pH 7.6, 140 
mM NaCI, 0.2 % Tween) and then incubated with pre-heated stripping buffer (62.5 mM 
Tris-HCL pH 6.8, 2% SDS, 100 mM J3-mercaptoethanol) for 20 minutes in a 55°C water 
bath with gentle shaking. The membrane was then washed with buffer A and processed 
for immunoblotting. 
Coomassie blue staining- Gels were incubated in 100 m1 staining buffer (0.25 % 
Coomassie blue in 45 % methanol, 45 % H20, 10 % glacial acetic acid) for 30 minutes at 
room temperature. Stained gels were then washed in 100 ml of destain solution (45 % 
methanol, 45 % H20, 10 % glacial acetic acid) and incubated for 30 minutes. Gels were 
then washed in fresh destain solution every 30 minutes until protein bands were visible. 
Additional methods- DDTl-~2 cells were stably transfected with pcDNA3.AGS3 by 
DNA/calcium phosphate coprecipitation (84). For antipeptide antisera, AGS3 peptides 
(P-32 T306~I436, P-22 D528-G550 and 9808 V625-S650) were synthesized and 
conjugated for generation of rabbit polyclonal antisera using the Peptide Synthesis and 
Antibody Production Facility at the Medical University of South Carolina. Each of the 
three antisera specifically recognized GST-AGS3 at reasonable dilutions (1:500 to 
1:2,000) of serum and were affinity purified. 
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Yeast two-hybrid methods 
Generation of Bait Constructs- AGS3-TPR constructs TPRLong (Met1-lle462) and 
TPRShort (Met1_Gly337) were generated ~y PCR. Restriction digested PCR products 
were subcloned into pGBKT7 to generate the TPRL and TPRS bait constructs. TPRL, 
TPRS and empty pGBKT7 vector were transformed into AHI09 by the lithium acetate 
method (201). Positive transformants from SD -TRP plates were re-streaked onto fresh 
SD- TRP plates and stored at 4°C. Protein extracts of pGBKT7-TPRL, pGBKTI-TPRS 
and pGBKTI AHI09 strains were obtained by the UrealSDS method (202). Expression 
of bait fusion proteins was confirmed by immunblotting with Anti c-Myc. Basal activity 
of bait strains was assayed by nutritional selection. 
Yeast two-hybrid screening- AHI09 yeast strain expressing a Gal4BD-TRPL fusion as 
bait were mated with Y187 yeast strains expressing fusion proteins of mouse 11 day old 
embryo cDNAs and Gal4AD by following the manufacturer's protocol. The mated yeast 
culture was plated onto 120 QDO (SD -TRP, -LEU, -HIS, -ADE) plates which were then 
incubated at 30°C for 7 days. Ten colonies from each plate were re-streaked onto QDO 
plates and allowed to grow for 3 days. Colony-lift J3-gal assays were performed on the 
master plates as described (203). Clones were scored based upon the time required to 
demonstrate J3-gal activity. The top ten percent (120 colonies) based on this scoring 
system were re-streaked onto QDO plates and were assayed again by the colony lift J3-gal 
assay. Yeast plasmid DNA was isolated from the top sixteen colonies and subsequently 
transformed into chemically competent KC-8 cells. Transformants containing the prey 
vector containing the LEU2 reporter gene were selected by plating onto M9 -LEU plates. 
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Bacterial plasmids isolated from KC-8 transformants were transformed into XLI-Blue 
cells for large-scale production. 
Re-streaking of yeast colonies Yeast colonies of 2-3 rom were picked with sterilized 
toothpicks and vortexed in 100 J.1L of sterile water. 2.5 J.1L of the re-suspended yeast 
were placed upon the appropriate yeast media plates. For most applications a 5 x 5 grid 
was used as a template to spot yeast upon 100 mm plates. 
/3-Gal colony lift assay 75 mm diameter circular whatman filter lifts of yeast colonies 
were flash frozen in liquid nitrogen and were placed in a 100 mM dish atop another 75 
mm diameter filter pre-soaked in 2.5 mL Z-buffer with X-gal (Z-buffer: 100 mM 
NaHP04 pH 7.0, 10 mM KCI, 1 mM MgS04; Z-buffer wI X-Gal: 100 mL Z-buffer, 0.27 
mL f3-mercapoethanol, 1.67 mL 20 mglmL X-gal in DMF). Time zero was set as the 
time the colony filters were placed in contact with Z-buffer. The earliest colonies 
(including the positive control) turned bluebetween 30 and 60 minutes. Clones were 
scored based on the time it took them to tum blue. Colonies turning blue after two hours 
were not included as positive clones. 
Secondary two-hybrid screening- Bait constructs in pGBKT7 were co-transformed with 
candidate prey constructs in pACT2 into yeast strain AH109 using the Lithium acetate 
method (201). Transformed yeast cultures were plated onto SD -TRP, -LEU plates to 
select for uptake of both plasmids. Five positive clones from each plate were re-streaked 
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onto QDO plates and allowed to grow for 3 days at 30°C. Colony lift b-gal assays were 
performed as described above. 
Protein interaction assays- The fragment of SITKII coding sequence isolated in the two-
hybrid screen was obtained by digesting the pACT2-SfTKll construct with Bco RI and 
Xho I. The purified fragment was subcloned into the pGEX5X2 vector such that the 
SlrKll reading frame was aligned with the GST reading frame. The pGEX5X2-SITKll 
construct was transformed into BL-21 competent cells. GST-SfTKII fusion protein was 
purified as described. 
Protein interaction assays were performed as described. Tissue lysates were 
generated using NP-40 lysis buffer as described above. Brain lysate (2.5 mg in 250 Jl.L) 
treated for 30 minutes with either 30 J.1M GDP or 30 uM GTPyS plus 10 mM MgCl2 was 
incubated with GST or GST -SITKII (500 nM) for one hour at room temperature. 
Protein complexes were captured by incubating the lysate-fusion protein mixture with 25 
uL 1:1 Glutahtione Sepharose 4B for 30 minutes at room temperature. The pelleted 
sepharose beads were washed 3 times with 500 J.lL NP-40 lysis buffer. After sample 
buffer was added to washed beads the mixture was boiled for 3 minutes and loaded onto 
SDS-PAGE gels. Immunoblotting was performed as described. 
AGS3-CE methods 
Promoter expression assay The 3 kb region upstream of the predicted start methionine of 
AGS3-CE, the first exon, first intron and part of the second exon were PCRed from 
genomic C. elegans DNA provided by Dr. Guy Benian. The PCR product was subcloned 
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into the pD96.04 vector such that the frame of the second exon matched with the frame of 
LacZ and GFP coding regions in the pD96.04 vector. This construct was co-injected with 
the rol-6 marker construct into 40 sub-adult C. elegans hermaphrodites using a micro-
injector (injection buffer: 20 mM KP04, 3 mM KCitrate, 2%PEG 6000, 100J,lglml 
plasmid DNA) (204). After recovery, the worms were placed on bacterial lawns and 
were left at room temperature for 20 hours. The injected parental worms were moved to 
a fresh plate and left at room temperature for 24 hours, during which time they laid eggs 
of transgenic offspring. From 20 plates containing -100 worms each we detected 12 
worms with the roller phenotype indicative of the uptake of plasmid rol-6. These 
individuals were analyzed for GFP using a fluorescent microscope. The worms were also 
assayed for LacZ activity using X-gal staining. Pictures of mounted worms were taken at 
40X magnification. 
X-gal staining olC. elegans Transgenic worms were washed with acetone and air-dried at 
room temperature on glass slides. 25 J.tl of staining solution (0.2 mM NaHP04 pH 7.5, 1 
mM MgCI2, 0.004% SDS, 10 mM FeCN, 7.S J.tglml kanomycin, 0.0025% X-Gal) was 
added and coverslips were sealed on top of the worms (205). After a 20 hour incubation 
at room temperature, GFP and LacZ staining was observed. 
RNAi Full length AGS3-CE in the pSK+ vector was obtained from the C. elegans est 
database of Yuji Kohara. AGS3-CE -GPR and AGS3-CE -TPR were isolated from the 
full length sequence and subcloned into the pSK+ vector. The AGS3-CE constructs were 
linearized by restriction enzyme digestion at their 5' and 3' ends. Single stranded RNA 
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was generated by using the Gibco T7 and T3 roMessage roMachine kits. Single stranded 
RNA representing the sense and antisense strands were mixed together, incubated at 100 
°c and brought to room temperature. Annealed, double stranded RNA (dsRNA) was 
distributed into aliquots and stored at -20°C. 
DsRNA of AGS3-CE was injected into the gonad syncitia of 30 sub adult wonns 
(injection buffer: 20 roM KP04, 3 roM KCitrate, 2%PEG 6000, 50J.1g/ml dsRNA) (190). 
After recovery, the worms were placed on bacterial lawns and left at room temperature 
for 20 hours. The injected parental worms were moved to a fresh plate apd left at room 
temperature for 24 hours, during which time they laid eggs of affected "RNAi" offspring. 
The parent was moved off of the plate containing the affected progeny. The RNAi 
offspring were evaluated by light microscope. 
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CHAPTER 4 
SPECIFIC AIM 1 
Identify and characterize the domains of AGS3 that interact with Go; subunits. 
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Introduction 
The identification and characteri~ation of novel G-protein regulators has been a 
major focus of interest in our laboratory. Using a functional screen for receptor-
independent activators of heterotrimeric G-protein signaling systems three AGS 
(Activators of G-protein Signaling), proteins were isolated. At the time when I entered 
the lab, these proteins'had not been shown to functionally interact with G-proteins outside 
of the yeast system. After generating initial data indicating that the C-terminal 74 amino 
acids of AGS3 could interact with purified G-proteins, I began to focus my efforts on 
AGS3. The discovery of a novel protein, AGS3, possibly acting as a G-protein regulator, 
left us with many questions to answer. Paramount among these was the potential 
association of AGS3 and G-proteins in endogenous tissue. A common method used to 
determine if proteins associate in cells or tissue is co-immunoprecipitation. The 
availability of AOS3 and G-protein antisera, together with successful co-
immunoprecipitation protocols in our laboratory, allowed these experiments to proceed. 
Sequence analysis of AGS3 revealed two distinct protein repeat domains, an N-
terminal TPR domain and a C-terminal region containing repeats that were termed GPRs 
based on data gathered in this aim. The region of AGS isolated in the yeast expression 
cloning system that was subsequently shown to interact with G-proteins contained one 
partial and one complete GPR. Initial BLAST results using AGS3 generated several 
proteins that were known to interact with G-proteins such as RGS12, RGS14 and LON. 
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The C-terminus of LGN containing four GPRs was isolated in a yeast-two hybrid screen 
using Gia2 as bait (151). Based on these-data, we hypothesized that the region of AGS3 
responsible for this interaction was the GPR domain. Since the GST pull-down assay had 
been used successfully by our laboratory, our approach was to use this technique to 
analyze protein-protein interactions of various AGS3 fragments. 
If our hypothesis about the GPR repeat was correct, then the domain constituted a 
novel Ga interacting domain. Aside from the RGS domain, no other accessory protein 
domain had been indicated as such. Thus we were afforded the opportunity to define this 
domain and report it as a signature Ga.-binding motif. With the advice and aid of Starr 
Hazard ill, our approach was to use computer algorithms to define the consensus repeat 
and then use this repeat to search for other proteins containing this domain. These 
searches would allow for 1) the discovery of other GPR containing proteins, 2) a 
consensus motif upon which to design mutants and 3) a platform upon which to design a 
peptide for further research. 
Results 
Does AGS3 interact with Ga subunits? 
Initial studies indicated that the carboxyl-terminal 74 amino acid fragment of 
AGS3 was active in the yeast functional screen and that this peptide fragment directly 
bound to Gia'(llS). We thus asked if full length AGS3 was complexed with Gia3 in 
lysates of rat brain or DDTl-:rvtF2 cells stably transfected with AGS3. As AGS3 
preferentially regulated GiaZ and Gia3 in the yeast functional assay (115), we first 
approached this issue by immunoprecipitation of Gia.3. Approximately 30% of brain 
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lysate Gia3 was immunoprecipated with a Gia.3 carboxyl terminus antibody. 
Immunoblots of membrane transfers containing Gia.3 immunoprecipitates indicated that 
AGS3 co-immunoprecipitated with Gia, in a nucleotide-dependent manner (Figure 4.1). 
The absence of Gf3 in the GTPyS treated samples provided internal controls for G-protein 
activation and subunit dissociation by added GTPySlMg2+. Immunoprecipitation 
experiments were also conducted with the AGS3 antisera P-32 raised againt the linker 
region (T406-I436). Although AGS3 was effectively immunoprecipitated by the P-32 
antisera in each cell/tissue extract, co--immunoprecipitation of Gia.3 was variable, which 
may reflect lower immunoprecipitation efficiency for P-32 and/or a masking of the P-32 
epitope in the AGS3-Ga, complex (data not shown). Nevertheless, these data indicated 
that a subpopulation of Gia3 and AGS3 exists as a complex in the cell and that this 
interaction is regulated by nucleotide binding to Ga.. 
Which domains of AGS3 are involved in G-protein interactions? 
The interaction between AGS3 and G-proteins was further explored in in vitro 
binding assays to define the regions of AGS3 actually involved in binding to Ga. We 
generated the amino terminal half of AGS3 (AGS3-TPR, MI-I462) and the carboxyl 
terminal half of AGS3 (AGS3-GPR, P463-S650) as GST fusion proteins (Figure 4.2). 
The AGS3-TPR, AGS3-GPR and the 74 amino acid carboxyl terminus (AGS3-CT, 
M577- S650) isolated in the original yeast functional screen were incubated with DDT1-
MF2 cell lysates. Proteins bound to the AGS3 subdomains were identified by 
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Figure 4.1 Co-immunoprecipitation of AGS3 with Gia3. A) Rat brain (2.5 mg) and B) DDT-AGS3 cell (1.25 mg) lysates 
were preincubated with 30 ~M GDP or 30 ~M GTPyS/25 mM MgCl2 at 24°C for 30 minutes. Lysates were then precleared and 
Gia3 immunoprecipitated. Membrane transfers were first blotted with AGS3 P-32 antisera and then stripped and sequentially 
reprobed with Gia and G~ antisera. The data are representative of 2-4 experiments. The input lane contains 1/10 of the lysate 
volume used for immunoprecipitation. IP - immunoprecipitation. IB - immunoblot. P-32 antisera was used for immunoblotting 
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Figure 4.2 Subdomains of AGS3 that interact with G-proteins. Subdomains of AGS3 A) were generated as glutathione-S-
transferase (GST) fusion proteins and purified following expression in bacteria for protein interaction studies. (B) Lysates were 
prepared from DDTcMF2 cells and 1 mg of lysate protein was incubated with 300 nM GST-AGS3 fusion proteins. Membrane 
transfers of bound proteins were probed with G-protein subunit antisera. B) TPR M1-I462, GPR P463-S650, CT M577-S650. 
Similar results were obtained in 3-5 individual experiments using different batches of lysate. The input lane contains 1/10 of the 
lysate volume used in each individual interaction assay. 
carboxyl terminal half of the protein (Figure 4.2). The TPR domain of AGS3 did not 
interact with Gial/2 or G~y (Figure 4.2). 
Within the C-terminal region of AGS3 that binds to Ga, there are four GPR 
motifs. Previous data indicated that the 74 amino acid at the carboxyl terminus of AGS3, 
containing one full and one partial GPR, was functional in the yeast functional screen. 
We then asked if each GPR domain was indeed capable of binding Ga. Each GPR motif 
was generated as a GST-fusion protein (Figure 4 .. 3) and evaluated in protein interaction 
assays using DDTl-1VlF2 lysates (Figure 4 .. 3). Each GPR motif bound Gial/2, although 
GPR I, at least in this context, bound less Go. than did GPR II-IV (Figure 4.3). These 
data suggest that interaction of AGS3 with Gia3 observed by coimmunoprecipitation 
experiments (Figure 4.1) reflects interaction of Gia3 with the GPR domains in AGS3. 
Characterization of the AGS3 domains responsible for Ga interactions. 
The core of the C-terminal GPRs of AGS3 exhibit 80-85% homology: GPR I -
E470 to R489, GPR II - E524 to R542, GPR ill - D572 to R590, GPR IV - D606 to R624. 
Four repeated GPR domains are also found in human LGN and the predicted C. elegans 
protein, AGS3-CE. The Drosophila protein PINS contains three GPRs in its C-terminus. 
Based upon computer projections, each of the repeated domains can exist as an 
amphipathic helix. GPR domains I-IV in AGS3, human LGN and AGS3-CE were 
evaluated by MAST (Motif Alignment and Search Tool) to determine their existence in 
other proteins in the databases. Initial searches returned four additional proteins that 
contained GPRs, two of which were members of the RGS family (Figure 4 .. 4). The other 
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Figure 4.3 Individual AGS3 GPR domains interacting with G-proteins. Subdomains of AGS3 A) were generated as 
glutathione-S-transferase (GST) fusion proteins and purified following expression in bacteria for protein interaction studies. (B) 
Lysates were prepared from DDTI-MF2 cells and 1 mg of lysate protein was incubated with 300 nM GST-AGS3 fusion proteins. 
The roman numbers correspond to the GPR domains in (A): GPR-I P463-E501, GPR-II S516-L555, GPR-III G563-T602, 
GPR-IV T602-S650. Similar results were obtained in 3-5 individual experiments using different batches of lysate. The input 
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Figure 4.4 Consens~s sequence for G-protein regulators. The four repeat domains in the carboxyl terminus half of AGS3, 
human LGN, the predicted C. elegans protein (AGS3-CE) were aligned and used to fonn a consensus sequence. Related 
sequences identified by the motif search program MEME are shown below the consensus. Red amino acids represent 'consensus 
residues and . blue amino acids represent proline residues. Asterixes over the sequence correspond. to positions of site-directed 
mutagenesis. 
PcpL7 (PQ0109) (pcp2) was recently isolated in a yeast two-hybrid screen using Goa as 
"bait" and may act as a guanine nucleotide exchange factor (152). Rap1GAP (P47736) is 
a GTPase activating protein for the small G-protein Rap-1A and was also identified in a 
yeast two-hybrid screen using Goa as "bait" (119). RGS12 (AF035151) and RGS14 
(0087737) are members of the RGS family (153) and have been a focus in the Siderovski 
laboratory. Presence of the motif in the RGS12IRGS14 Drosophila homolog Loco, a 
protein known to influence the activity of Goa, prompted the report of the repeat as the 
GoLoco domain (130). Based upon available reports they speculated that the GoLoco 
domain behaved as a Giloa GEF. Artemyev and colleagues recently re-visited the 
influence of these proteins on G-protein activity (206). 
Is the GPR domain required for Ga interactions? 
Analysis of GPRs I-IV in AGS3, human LGN, the predicted C. elegans protein 
and the motifs in PcpL7, RGSI2, RGS14 and Rap 1 GAP indicated a consensus sequence 
of FlDEXFILFDIEUMI.IIXRIKXQS/GXRMILDDQR. Other groups have labeled the 
repeat as GoLoco (130) and the LGN motif (207). We used AGS3-CT containing one 
complete GPR motif as a base for our mutagenesis studies. Substitution of phenylalanine 
at position eight with an arginine (F8R) was designed to break up the N-terminal 
hydrophobic patch by introducing a long, bulky, charged amino acid where the aromatic 
ring had been. Conversely, we introduced a phenylalanine at position twenty-three 
(R23F) to disrupt a conserved, charged position. The invariant glutamine at position 15 
was changed to an alanine to test its requirement for G-protein interactions (GI5A). 
Introduction these mutations into the AGS3-CT GPR motif eliminated interaction of 
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AGS3 with Gia2 and Gia.3 in crude cell extracts (Figure 4.5). The same fusion proteins 
were inactive in the yeast assay system (Data not shown). Of the three mutants, Q15A 
showed some binding to Ga. subunits. 
G18.1b 
The previous data indicates that the GPR motif may be diagnostic of protein function. 
Sequences entered into the database from genome sequencing projects may be analyzed 
for the presence of GPR domains, an indicator of G-protein regulatory activity. As stated 
""~ above, based upon the presence of GPR domains, both PcpL7 and RaplGAP were 
identified during the course of this study as putative G-protein regulators prior to the 
recent publications providing experimental evidence supporting this hypothesis (119, 
152). Screening of recently released sequences revealed another GPR containing protein, 
G18.lb. Indeed, when made as a GST-fusion protein, G18.1b was demonstrated to 
interact with purified Ginl (Figure 4.6). 
GPR Proteins 
Screens of the database for the GPR domain identified 10 protein groups, each 
representing a distinct gene. Including species homologs, the number of non-redundant 
GPR containing proteins is 26. Figure 4.7 depicts the domain structure of GPR proteins. 
Families include the AGS3 family, the pcp-2 family, the G18.lb family the RGS12/14 
family and the Rap 1 Gap family. The AGS3 family can be sub-divided into the AGS3 
and LGN sub-families. RGS12 and RGS14 constitute distinct proteins of the RGS12/14 


















Figure 4.5 Interaction of wild type and mutant AGS3 with G-proteins. The AGS3 cDNA isolated in the yeast screen and 
shown to interact with Ga subunits (Figure 1.7) was modified by site-directed mutagenesis to disrupt conserved residues within 
the GPR motif defined in Figure 4.4. GST fusion proteins were generated in bacteria. The number of the amino acids altered in 
the mutant constructs (F8R, Q15A and R23F) refers to their position in the sequence found in Figure 4.4. The GST -AGS3 fusion 
proteins were then added to DDTI-MF2 cell lysates containing 30 f..tM GDP and processed to determine interaction with 
endogenous mammalian Gia2 or Gia3. Equal loading of individual samples was verified by amido black staining or 
immunoblotting with the AGS3 specific antisera (lower panel). This experiment was repeated twice with similar results. The 
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Figure 4.6 Interaction of predicted protein G18.1b with G-protein subunits. G18.1b cDNA (AJ243937) was obtained from 
the IMAGE Consortium est database (image.llnl.gov) and used to 'generate ,a GST-G18~lb fusion protein. Purified GST, GST-
GPR and GST-G18.1b (300 nM) were incubated with 100 nM purified Gia1 in the presence of 10 f..lM GDP. Protein complexes 
Isolated by precipitation with glutathione-sepharose were analyzed by immunoblotting. The data presented are the results of two ' 
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Figure 4.7 GPR Proteins. Representative GPR containing proteins and their domain structure are depicted schematically. In 
addition to TPR (black) and GPR gray) domains GPR proteins contain the following protein domains: Rap Gap- GTPase 
activity for Rap; PDZ- Protein interaction domain with C-termini of other proteins; PTB domain- phosphotyrosine binding 
domain; RBD- Raf-like Ras binding domain; DNAJ- DNA molecular chaperone domain. CG 13789 is a predicted protein from 
D. melanogaster and Y50F7 A.l is a predicted protein from C. elegans. 
proteins from lower organisms, C.elelgans Y50F7 A.l and D.melanogaster CG 13789, fall 
into neither category and contain single copies of weak: GPRs. 
Disscussion 
Demonstration that AGS3 could interact with G-proteins not only helped to 
validate the yeast expression cloning system, but it supported the hypothesis that AGS3 is 
a G-protein regulator. Co-immunoprecipitation experiments suggested that AGS3 and 
Go. subunits are complexed within mammalian cells and tissue and that their interaction 
is dependent upon the activation-state of the alpha subunit. Subsequent analysis of AGS3 
localized its Go. binding domain to a region in the carboxy terminus containing four 
previously unknown repeats which we termed GPR (G-protein regulatory) domains. 
With the exception of a weak interaction between GPRI and Go., individual GPR 
repeats readily bind Ga.. Moreover, mutations of the GPR disrupted protein-protein 
interactions with Ga. and abolished activity in the yeast expression cloning system. 
Using the GPR domains of AGS3 family members, a consensus sequence was obtained 
by computer algorithms. Searches with this domain revealed the presence of GPRs in 
known G-protein regulators as well as in predicted proteins. The interaction of an 
unknown GPR containing protein, GI8.1b, with Go. supported our claim that the GPR is 
diagnostic of a G-protein regulator. The GPR is found in over 10 proteins, most of which 
have been linked to G-protein function. 
The data gathered in this aim has been the foundation for many of my other 
studies as well as a basis for new projects and collaborations. Our discovery that AGS3 
can interact with G-proteins not only introduced a novel G-protein regulator, but the 
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additional finding of a Gu binding motif introduced a novel signaling motif, the GPR 
domain. Most of the data presented in this aim were published in two me papers (115, 
198). Data gathered on G18.1b has not been submitted for publication. Methods used in 
this aim to define Ga binding domains have been submitted for publication in Methods in 
Enzymology (208). Some of the constructs used in this aim, most notably the GST -GPR 
fragment, have been used in collaboration with Dr. Stephen Graber of West Virginia 
University and Dr. Nickoli Artemyev of the University of Iowa. Natochin and co-
workers used the GPR domain in his publication characterizing the biochemical 
properties of AGS3 (209). Peterson has headed efforts to characterize the properties a 
peptide derived from the AGS3-GPR repeat. Using variations of the assays presented in 
this aim, he was able to show that the GPR peptide can block protein-protein interactions 
(210). Based upon characterization of GPR mutants, he was also able to duplicate 
findings that OPR mutant peptides do not interact with G-proteins (210). 
The discovery of the GPR domain has not only been a foundation for our 
laboratory, but it has added an additional motif to the well-studied field of G-proteins. 
Beside receptor, GJ3y and effectors only one protein family is known to interact with On 
subunits, the RGS family. The ROS domain and the GPR domain do not share any 
similarity nor are their functions shared. RGS proteins contain one copy of the RGS 
domain, giving the protein its GAP activity. GPR-containing proteins, which are 
otherwise unrelated, contain from one to four copies of the domain. Our data indicate 
that one domain is capable of binding to Ga., suggesting that the GPR domain serves as a 
Ga. anchor. For proteins such as ROS12 and RGS14, the presen~e of a GPR domain may 
provide an additional Ga binding surface working in concert with the RGS domain. 
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the protein (119). In this regard, the GPR is a Ga anchor on an "effector" molecule, 
Rap 1 GAP. The Rap 1 GAP family member RaplGAPll is a mediator of Gia stimulation 
of ERK (211). Initial studies with Pcp-2 suggested that Pcp-2 acted as a GEF for Goa 
subunits (152). The influence of Pcp-2 on Gn function has since been re-examined 
calling these data into question (206). The hypothesis that the GPR is a Ga anchor is not 
completely solid since some proteins such as the AGS3 splice variant expressed in the 
heart contain little more than GPR domains (212). Such proteins imply that the GPR 
regulates the function of Oa subunits. Our efforts to characterize the effects of the OPR 
domain on Ga function are presented in chapter 6. 
. Another distinguishing feature of the GPR domain is its size. The Gn binding site 
on RGS proteins is a 120 amino acid region known as the ROS domain. The GPR repeat 
is a smaller domain, whose core is less than twenty amino acids. Therefore, in addition 
to being a signature Gc:x binding motif, the GPR may also be developed as a biological 
tool. Subsequent aims will demonstrate that the function of the domain has been 
determined. Currently studies are underway to develop the GPR peptide as a method of 




SPECIFIC AIM 2 
Determine if AGS3 specifically interacts with G-protein subunits 
91 
Introduction 
Heterotrimeric G-proteins are a diverse set of signaling proteins involved in a 
wide array of biological pathways. As mentioned in the literature review, diversity of G-
protein subunits contributes to the generation of signaling specificity. Different Oa 
families are distinguished not only by sequence, but also by the class of effectors that 
they engage. In addition, some classes of Ga subunits seem to signal through their GJ3y 
subunits with relatively higher frequency_ G-protein regulators generally act upon a 
specific Ga family and therefore affect a subset of signaling systems. The RGS family 
contains GAPs for the Gin, Gqa and Gl2/13a families but not the Gsa class. In fact, 
most G-protein regulators act upon the Gia family whereas few Gsa regulators have been 
described. Since the NG-108 activator was shown to activate brain G-protein, which 
contains mostly Gia family members, the initial expression cloning screen used a 
modified Gia2 subunit to identify G-protein activators. Therefore we initially focused 
our AGS3 protein-protein interaction studies upon the Gia class. To further characterize 
the novel G-protein regulator, we sought to determine if AGS3 interacted specifically 
with G-protein subunits. 
Based upon the yeast expreSSIon cloning system, the activity of AGS3 was 
selective for Gia2 and Gia3 heterotrimers. AGS3 did not activate heterotrimers 
containing Gsa, Gl6a or the endogenous yeast Ga, GPAI (Figure 1.4). The initial 
motivation for this aim was to verify if AGS3 selectively interacted with Gia subunits. 
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The previous aim clearly demonstrated that AGS3 interacts with Ga. subunits in co-
immunoprecipitation and GST pull down experiments. We used these techniques to 
assess the preference of AGS3 for Ga. subunits. Two sources of G-proteins were used: 1) 
G-proteins as components of cell/tissue lysates, 2) purified G-protein subunits. Through 
a long-tenn collaboration with Dr. Hildebrandt we were generously provided with 
specific G-protein antisera. Our collaboration with Dr. Graber of West Virginia 
University was the source of purified Gia.1-3 and Goa. subunits. Gsa. and Gqa. were 
kindly provided by Dr. Ross of the University of Texas Southwestern. Transducin 
subunits and heterotrimers were gifts of Dr. Hamm of Northwestern University. Using 
cell/tissue lysates as our source of G-protein, the preference of AGS3 for Ga. subunits 
could be determined. With the purified subunits, a more standardized comparison 
between affinities of AGS3 for Ga. subunits could be made. 
The discovery reported in the previous aim that each GPR repeat could 
independently bind to Ga. raised additional questions about the AGS3-Ga interaction. 
Specifically, we wanted to know if AGS3 could simultaneously interact with mUltiple Ga. 
subunits. We designed a co-immunoprecipitation experiment such that multiple Ga. 
interactions could be tested. Immunoprecipitates from a mixture of Gia.2 and Gia.3 using 
Gia3 antisera were evaluated in the presence and absence of AOS3-GPR. Our 
hypothesis was that, in the presence of AGS3, Gia2 would be present in Gia.3 
immunoprecipitates. This experiment also assessed whether AGS3 could simultaneously 
interact with different Ga. subunits. This approach is limited in that a rigorous 
determination of AGS3-Ga. stoichiometry could not be determined. 
93 
Results 
Does AGS3 interact with specific Ga subtypes? 
The preceding aim clearly established the interaction of AGS3 with Ga within the 
cell and defined the regions of AOS3 involved in G-protein binding. We then asked if the 
interaction of AGS3 with Oa was selective for different O-protein families. We 
approached this question using crude tissue/celllysates and purified Oa subunits. The 
AOS3-GPR GST fusion protein was incubated with rat brain lysate and bound proteins 
identified by immunoblotting with Oa specific antisera. AOS3-GPR effectively bound 
Gial-3, but not Gsa, Goa, Gqa. or GJ3y (Figure 5.1). Based upon the comparison of the 
signal intensity in the input versus sample lane, it is estimated that AGS3-GPR binds 
-20-% of the total Gia protein in the lysate sample. Similar results were obtained in 
DDT}-:MF2 cell lysates. Each of the protein interaction experiments in the tissue/cell 
lysates was done in the presence of GDP, which would stabilize heterotrimeric Ga.~y; 
however, immunoblotting with G-protein a. subunit antisera indicated that AGS3 was 
complexed with Giain the absence of Gf3y (Figure 5.1). 
Does AGS3 interact with specific members of the Giloa family? 
The selectivity of AGS3 for different G-proteins within the Gilo family was also 
observed using purified Ga. subunits. AGS3 bound to Gial-3 and purified Gta., but it did 
not interact with Gsa. and weakly bound Oqa. and Goa. (Figure 5.2). A similar profile of 
AGS3 selectivity for Ga. subunits was observed in a yeast functional assay (115). 












Figure 5.1 Selective interaction of AGS3 with G-proteins from brain lysates. One milligram of lysate protein from rat brain 
was incubated with 300 nM GST -AGS3 fusion (TPR MI-I462, GPR P463-S650, CT M577 -S650). Membrane transfers of bound 
proteins were probed with the indicated antisera. The input lanes represent one tenth of the G-protein used in each interaction 
assay. Membrane transfers of bound proteins were probed with the indicated antisera with intervening stripping of the blot as 
described in the methods section. The Gia3 antibody exhibits some cross reactivity with Goa that likely accounts for the broad 
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Figure 5.2 Selective interaction of AGS3 with purified G-proteins. Recombinant Ga (100 nM) or purified Gta (100 nM) were 
incubated with 300 nM GST or AGS3-GPR. All interactions were done in the presence of 10 JlM GDP. The input lanes represent 
one tenth of the G-protein used in each interaction assay. Membrane transfers of bound proteins were probed with the indicated 
antisera. Similar results were obtained in 2-3 separate experiments. 
and Gia (Figure 5.2) indicated a higher apparent affinity of AGS3 for Gi versus Go/Gq, 
which may account for the inability of AGS3 to interact with Gqaf3y and GoaJ3y in brain 
lysates (Figure 5.1). 
Does AGS3 interact with multiple Ga subunits? 
The interaction between individual GPRs and Ga subunits suggested that AGS3 
is capable of binding mUltiple Gia subunits. To address this issue, we asked if a GST-
AGS3 fusion protein containing GPRs I-IV indeed bound more than one Gia. at the same 
time. A GST-AGS3 fusion protein containing GPRs I-IV was incubated with a mixture of 
Gia3 and Gia2. Samples were then immunoprecipitated with antisera directed against 
the carboxyl terminus of Gia.3. In the presence of AGS3, Gia2 was also found in the 
Gia.3 immunoprecipitate (Figure 5.3). Gia2 was not found in the Gia.3 
immunoprecipitate in the absence of AGS3 (Figure 5.3). These data clearly indicate that 
AGS3 is capable of binding more than one Gin subunit consistent with a putative role of 
AGS3 as a scaffolding protein within a larger signal transduction complex. 
Discussion 
The results of experiments performed in this rum demonstrated a specific 
interaction between AGS3 and Gial-3. Additionally, AGS3 was shown to be capable of 
interacting with multiple Go. subunits. G-protein interaction assays using rat brain lysate 
revealed that AGS3 selectively pulled down Gia subunits. The finding that AGS3 does 
not interact with Goa is surprising, given the expression of both proteins and the high 
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Figure 5.3 Interaction of AGS3 with multiple Gia subunits. Gia2 (200 nM) was incubated with Gia3 (50 nM) in the 
presence or absence of the AGS3-GPR GST -fusion protein (250 nM). Samples were immunoprecipitated with Gia3 antisera 
and processed for SDS-P AGE as described in the methods section. Membrane transfers were immunoblotted with the indicated 
antisera. The arrows to the left indicate the migration of the indicated proteins. Similar amounts of Gia3 antisera were pelleted 
in each lane as indicated by detection with secondary antibody. Input lanes represent one tenth of the the sample processed for 
immunoprecipitation. This experiment is representative of 3 such experiments. 
in the brain (14, 35) and AGS3 expression is enriched in brain (198, 212). Experiments 
using purified Oa subunits confirmed what was observed in lysate experiments. 
Comparing the relative amounts of G-protein in the input lane to the amount bound by 
AGS3-GPR, the selectivity of AGS3 for Gial-3 is apparent. Experiments validating that 
AGS3 can bind to multiple Oa subunits also confinned that the binding of one type of 
Ga subunit does not exclude the binding of another. Another degree of specificity 
discovered in a previous aim is the preference of AOS3 for GDP-bound Ga subunits 
(Figure 4.1). Collectively these experiments suggest that AGS3 specifically influences 
Gia signaling pathways and that AGS3 is functioning through multiple~ simultaneous 
interactions with GDP-bound subunits. 
The data presented in this chapter give us better resolution of the nature of the 
AGS3-Ga interaction. Again, the results of these experiments validate the data obtained 
from the expression cloning system. By knowing which O-protein signaling pathways 
are being affected~ the function of AGS3 can be more efficiently examined. 
Demonstration that AGS3 interacts with multiple Ga. subunits suggests that AGS3 might 
serve a role as a Ga. scaffolding protein. The absence of Gl3v from GST -GPR pulldowns 
in the presence of GDP stimulated a series of work to assess if AOS3 influenced G-
protein subunit interactions. Data gathered in this aim were published in the Journal of 
Biological Chemistry (198). 
Compared with published reports of other proteins containing GPRs, the 
selectivity of AGS3 for Gia subunits is relatively limited. Whereas our data restricts 
AGS3 binding to Gia.I-3 and transducin, DeVries reported that AGS3 interacted with 
Goa. in the context of a two-hybrid screen (213). LON, which was originally isolated in a 
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yeast two-hybrid screen with Gia2 (151), has also been isolated in yeast two-hybrid 
screens with Gia.3 and Goa. (152). Both pcp-2 (152) and Rap 1 Gap (119) were identified 
by yeast-two hybrid screening as Goa interacting proteins. Pcp-2 also interacted with 
Gia but not Gsa in GST pulldown experiments (152). RaplGap was also identified as a 
GZ(l (214) and Gicx.2 (119) interacting protein, but was not found to interact with Gsa. or 
Gqa. (206). Discovery of the GoLoco domain stemmed from observations that the 
RGS12 homolog in D. melanogaster, loco, could regulate the function of Goa. 
Mammalian RGS12 and RGS14 serve as GAPs for Gia. and Goa. but not for Gqa. and 
Gsa. (215). The variability existing between GPR proteins can be explained by variations 
in the repeat amino acids. In the case of RapIGAP, the most promiscuous GPR protein, 
the GPR repeat begins at amino acid 10 leaving out a hydrophobic, aromatic region 
conserved in most GPRs. AGS3 (115, 198), LGN (151) and RaplGAP (119) each 
showed preference for the inactive state of Ga. subunits whereas Pcp-2 did not display 
any selectivity for GDP vs. GTPyS bound Ga. (152). RGS proteins nonnally prefer the 
transition state of Ga. subunits. No comparisons have been made between RGS12/14 
selectivity and other RGS protein selectivity for Ga. activation states. 
The suggestion that AGS3 selectively interacts with Gia. subunits over Goa. is 
remarkable considering the expression profile for AGS3. Not only is the interaction 
specific for SUbtype, but it is specific for the conformation of the alpha subunit. AGS3 
binds to the GDP-bound conformation of Gia. subunits, the same confonnation that GJ3y 
interacts with. Interestingly no G~y was found in protein complexes anchored by AGS3-
GPR. Either AGS3 is accessing a pool of free Oia. subunits or Oa. bound to AGS3 no 
longer are able to bind to OJ3y. As stated above, this finding led us to the hypothesis that 
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AGS3 might influence G-protein subunit interactions. Most G-protein effectors and 
regulators only have a single G-protein binding domain therefore making the mUltiple Gu 
binding domains on AGS3 family members unique. The phenomenon is not 
characteristic of GPR-containing proteins since most have only a single repeat. If the 
GPR domain can regulate G-proteins, then AGS3 might be involved in rapid regulation 
of G-protein signaling. An unlikely scenario is that G-proteins act upon AGS3 in sets of 
four to exert biological function. 
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CHAPTER 6 
SPECIFIC AIM 3 
Determine the mechanism by which AGS3 activates G-protein signaling. 
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Introduction 
The yeast expression cloning system was designed to isolate the NG-108 activator 
(141) and any other putative G-protein activators. All known G-protein activators, 
including the factor isolated from NG-108 membranes, were Gn GEFs, guanine 
nucleotide exchange factors. AGS proteins were isolated based upon their ability to 
activate the pheromone response pathway, a Gf3y mediated pathway. Therefore these 
proteins were each able to liberate G~y, allowing it to engage effectors. Manipulations of 
the yeast system indicated that each AGS protein was using a distinct mechanism to 
release Gf3y. Efforts to determine if AGS proteins were GEFs led to the surprising 
finding that AGS3 could activate the yeast expression cloning system without requiring 
nucleotide exchange. Moreover, the activity of AGS3 was not antagonized by over-
expression of an RGS protein (Figure 1.5). Since AGS3 was not a GEF, it likely 
represented a novel class of G-protein activators. Therefore the purpose of this aim was 
to determine the mechanism by which AGS3 activated G-proteins. 
One hypothesis concerning AGS3 function was that AGS3 might be influencing 
heterotrimeric G-protein subunit interactions. Figure 6.1 depicts our notion that AGS3 
could bypass the formation of GaGTP and liberate Gf3y by stimulating subunit 
dissociation. Such a mechanism of activation had not been described in the literature for 
heterotrimeric G-proteins. Our approach was to use protein-protein interaction 











GaGTP + GttY - GPCR* -AGSI 
+ 
Effectors 
Figure 6.1 AGS3 and the activation/deactivation cycle. G-proteins are regulated by activating proteins known as GEFS and 
negative regulators known as GAPS. GEFs and GAPs control the available pool of GaGTP in a given signaling system. AGS3 
was not abolished in yeast strains expressing a Gia2 mutant incapable of binding to GTP. Therefore AGS3 was not likely 
acting as a GEF. Over-expression of a GAP, RGS4, did not antagonaze AGS3 activity also suggesting that AGS3 did not 
require the formation of GaGTP. AGS3 was possibly acting at the level of subunit dissociation 
designed our GST pull down and immunoprecipitation assays to analyze AGS3-G-protein 
complexes. If AGS3 was influencing G-protein subunit interactions then protein 
complexes anchored by AGS3 would contain only Ga and not GPy in the presence of 
GDP. H this hypothesis was correct then AGS3 and Gfiy would- be expected to compete 
for binding to Ga. We could test this hypothesis by using GST -pull down experiments. 
Modifications of the original yeast screen suggested that AGS3 was not a OEF. 
Outside of the yeast system, the influence of AGS3 on the nucleotide binding state of G-
proteins had not been determined. As an approach to determine if AGS3 influenced the 
activation-state of G-proteins, we used GTPyS binding assays. In the presence of the 
non-hydrolyzable analog of GTP, GTPyS, Ga subunits bound to GDP will undergo 
nucleotide exchange. This process of nucleotide exchange can be monitored by using 
GTpt5S. GTPyS binding assays were well-established in our laboratory, where they had 
been used to detect activators (141). Early experiments by Catalina Ribas showed that 
AGS3-CT did not stimulate GTPyS binding to Ga subunits but those experiments used 
low total binding to Ga subunits. We altered the system to detect if AGS3 was inhibiting 
GTPyS binding by raising the level of total binding. Through our collaboration with Dr. 
Graber we obtained purified Ga subunits used in the nucleotide binding assays. 
G-protein regulators can influence the transfer of signal from receptor to G-
protein andlor they can influence the activation state of G-proteins independent of 
receptor. GTPyS binding experiments with AGS3 addressed the latter, but we had no 
data concerning the former. Most of our experiments involved purified G-proteins or G-
proteins in the context of a cell or tissue lysate. The influence of AGS3 on the 
receptor/G-protein complex was yet to be addressed. Our discussions with Dr. Graber 
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engendered the idea that we could test the influence of AGS3 on receptor/G-protein 
signal transfer with high affinity agonist binding assays. In the absence of G-proteins, 
receptors adopt a low affinity for agonist and in the presence of heterotrimers adopt a 
high affinity for agonist. Since Dr. Graber's laboratory had an established system to 
study high affinity agonist binding, we asked them to test the influence of AGS3 on the 
formation of the high affinity state of G-protein coupled receptors. If our hypothesis was 
correct concerning the ability of AGS3 to dissociate heterotrimers, then the high afinity 
state would be disrupted. 
Results 
Can AGS3 influence G-protein subunit interactions? 
The ability of AGS3 to dissociate heterotrimers was addressed by comparing 
Ga.GDP pulled down with GST-AGS3 with GaGDP subunits immunoprecipitated from 
the same batch of lysate. AOS3-CT preferentially interacted with GaGDP versus 
Ga.GTPyS in pulldown assays with crude cell lysate (Figure 6.2). Despite the presence of 
GDP, which would stabilize the G-protein heterotrimer, the AGS3-GaGDP complex 
from the mammalian cell lysate did not contain GJ3y. In contrast, Gf3y subunits were 
readily detected when GaGDP was isolated from the same cell extract by 
immunoprecipitation with a Ga subunit antibody (Figure 6.2). In a reciprocal experiment 
N-terminally His6 tagged Gia2 was used as an anchor to pull down protein complexes. 
HiS6- Gia2GDP and bovine brain GJ3y were incubated in the presence and absence of 
GST and GST-AGS3-CT. Using a nickel resin, protein complexes were captured and 
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Figure 6.2 Absence of GJ3y in AGS3-Ga protein complexes. 225 J.!l of lysate containing GDP (30 J.!M) or GTPyS (30 J.!M) 
were incubated with GST or GST-AGS3 (300 nM) for 30 minutes at 24°C. 25 J.!l of a 50% slurry of glutathione-sepharose was 
added to bring down protein complexes. Bound proteins were solublized and processed for SDSIP AGE. Gia3 was 
immunoprecipitated as described in the Methods section. The input refers to 10 J.!l of the incubation mixture used for either the 
interaction or immunoprecipitation experiments. Bound proteins were solublized and processed for SDS/PAGE and 
immunoblotting of membrane transfers. Gia subunits were detected with the Gia3 antibody and GJ3 was detected with an 
amino terminus antibody. Experiments were repeated four times with similar results. 
Gj3y was observed for the control and GST treated samples, but not for the samples 
treated with GST-AGS3-CT (data not shown). These data support the hypothesis that 
AGS3 activates G-protein signaling by influencing subunit interactions. Alternatively, it 
is possible that AGS3 is selectively interacting with a population of Ga in the cell that 
exists independent of Of3y and sub serves unexpected functional roles. 
As both AGS3 and GJ3y interact with the GDP-bound conformation of Ga, the 
two proteins may actually compete with each other for interaction with Ga and thus 
AGS3 would essentially promote subunit dissociation in the absence of nucleotide 
~\: exchange. This issue was addressed by determining the influence of G(3y on the 
interaction of AGS3 with Gta. We first compared the ability of AGS3 to interact with 
purified Gta. versus heterotrimeric Gt (Figure 6.3). At equimolar concentrations of 
purified Gta. and heterotrimeric Gt, AGS3 bound equivalent amounts of Gta. As 
observed with the AGS3-Gia complex isolated from tissue/cell lysates, Gj3y was not 
present in the AGS3-Gta. complex isolated from purified heterotrimeric Gt, indicating 
that AGS3 effectively dissociated Gt from GJ3y. We thus asked if GJ3y would interfere 
with formation of the AGS3-Gta. complex. In these experiments, Gta. was first incubated 
with equimolar or excess O(3y to generate heterotrimeric Gt prior to exposure of the 
complex to AGS3. The interaction of AGS3 with Ga was not altered by GJ3y at 
concentrations equivalent to Gu, as observed in the experiments using heterotrimeric Gt 
(Figure 6.4). However, the interaction was completely blocked by lO-fold higher 
concentrations of G(3y (Figure 6.4), indicating that AOS3 and Gfiy are effectively 





















Figure 6.3 Influence of G~y on the interaction of AGS3 with Gta. AGS3-GPR (300 nM) was incubated with purified Gta 
or Gta~y (100 nM) and processed for protein interaction studies. The data presented are representative of five individual 
experiments with Gta and two experiments with Gta~y using different batches of fusion proteins. The blot was first probed 
with the Ga antisera and then stripped for reprobing with the G~ antisera. The input lane contains 1/10 of the lysate volume 
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Figure 6.4 Competition ofG~y with AGS3 for Gta binding. AGS3-GPR (100 nM) was added to tubes containing Gta (50 
nM) that had been preincubated with G~y (50 or 500 nM) and samples processed for protein interaction assays. Similar data 
were obtained in two experiments. The input lane contains 1/5 of the lysate volume used in each interaction assay. 
How does AGS3 influence the activation state of G-proteins? 
AGS3 and GJ3y compete for binding to GaGDP. Since GJ3y is known to inhibit 
GDP dissociation from the Ga. subunit, we hypothesized that AGS3 might act in a similar 
manner to regulate the activation state of Ga.. To address this issue, we asked if AGS3 
influenced the guanine nucleotide binding properties of Gia.. AGS3-GPR blocked the 
binding of GTPyS to Gia.l (ICso -- 0.1 J.1M) (Figure 6.5). We had previously identified 
key amino acid residues in GPR-IV that disrupted binding of AGS3-CT to Gia. We next 
examined the effect of this series of AGS3-CT mutants on GTPyS to Gia,l. The AGS3-
CT peptides containing GPR mutations that resulted in a loss of binding to Gia. in protein 
interaction assays (F609R, R624F) (115) were also ineffective at inhibiting GTPyS 
binding to Gia.l (Figure 6.5). These data, along with the results obtained in protein 
interaction experiments where AGS3 preferentially binds GaGDP versus Ga.GTPyS, 
suggest that AGS3 actually stabilizes the GaGDP or nucleotide-free conformation and 
functions as an inhibitor of guanine nucleotide exchange on Ga. These biochemical data 
are consistent with the functional properties of AGS3.in S. cerevisiae in that the action of 
AGS3 did not require the generation of GaGTP, and was not antagonized by over-
expression of the GTPase activating protein RGS4 (115). 
Can AGS3 influence the transfer of signal from receptor to G-proteins? 
The AGS3-GPR motif can influence subunit interactions by interfering with GJ3y 
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Figure 6.5 Effect of AGS3-GPR on nucleotide binding to Ga. A) GTPyS binding (1.0 uM GTPyS, 4 x lQ4 dpmJpmol) to Gial 
(100 nM) was measured in the presence of increasing concentrations of GST or GST-GPR. Data are expressed as the % of 
specific binding (-5 pmol) observed in the absence of GST or GST-GPR. B) GTPyS binding (0.5 uM GTPyS, 4 x 104 
dpmJpmol) to Gial (100 nM) was measured in the absence or presence (1 uM) of GST, AGS3-GPR, AGS3-CT and AGS3-CT 
constructs containing mutations that disrupt AOS3-CT binding to Oa in protein interaction assays (4). Data are expressed as the 
% of specific binding (-3.1 pmol) observed in the absence of GST. Data in (A) and (B) are presented as the mean +1- S.E. of 
two experiments. 
GPR domain on subunit interactions and nucleotide exchange would have significant 
implications for signal processing. First, interaction of the AGS3-GPR motif with Ga 
would release Gl3y for regulation of downstream signaling events, while stabilizing 
GaGDP (115). A second implication of stabilization of GaGDP by a GPR domain is 
related to receptor G-protein coupling. We addressed this issue experimentally using a 
membrane assay system where receptor-G-protein coupling is reflected as high affinity 
binding of agonists. The high affinity binding of agonist observed upon reconstitution of 
the membrane-bound 5-HT1A receptor with Oi was inhibited by addition of GST-GPR 
but not GST alone (Figure 6.6). These data confirm that AGS3 can disrupt heterotrimer 
formation in the presence of G-protein coupled receptors. 
Discussion 
The results of experiments in this aim defined the mechanisms by which AGS3 
activates G-protein signaling. Protein interaction experiments comparing Ga bound to 
AGS3 and Gu immunoprecipitated from cell lysates reveal that the Ga interacting with 
AGS3 does not interact with Gl3y despite the presence of GDP. When presented with 
purified heterotrimeric Gt, AGS3 only brings down Ota but not Ol3y subunits. Using 
increasing amounts of Gl3y, the interaction between AOS3 and Gta can be abolished 
confirming that AGS3 and Gf3y compete with one another for Ga subunits. AGS3 not 
only binds to Go:GDP, but it stabilizes Go: in its GDP bound form .. AGS3-GPR, in a dose 
dependent manner, blocks the conversion of Go:GDP to Go:GTPyS. Mutant AGS3 
proteins that do not interact with G-proteins do not influence their nucleotide binding 
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Figure 6.6 Influence of AGS3-GPR on receptor/G-protein coupling. Sf9 cell membranes expressing 5-HTIA receptors were 
reconstituted with G-proteins in the presence and absence of GPR peptides as described in the Methods section. The final 
concentration of protein was 13 jlM. Radioligand binding assays used a concentration of 3H-5HT near the Kd for the high 
affinity, guanosine 5'-(,-imido)triphosphate-sensitive binding site. The control bar indicates the amount of agonist binding 
observed in the absence of added G-protein. Data are presented as the mean ± S.E. from four independent experiments. 
of receptor stimulation. When placed into a reconstituted receptor/G-protein system, 
AGS3-GPR abolished the high affinity state suggesting that AGS3 disrupted heterotrimer 
formation and thereby influenced the transfer of signal from receptor to G-protein. 
The findings resulting from this aim delineate the mechanism by which AGS3 
activates G-protein signaling and distinguish AGS3 from other known G-protein 
regulators. Beside the discovery that the N-terminus of caveolin can inhibit nucleotide 
exchange of G-proteins (81), this is the only protein known to act as a heterotrimeric G-
protein GDI, guanine nucleotide dissociation inhibitor. With the exception of the 
receptor reconstitution experiment performed in Dr. Graber's laboratory, the data 
presented in this aim were published in the Journal of Biological Chemistry (115, 198). 
The ODI property of AGS3 was also subsequently verified by two other groups led by 
Artemyev and Devries (209, 213). Natochin and co-workers used our fusion protein 
constructs in assays similar to those described in this chapter but in the 
rhodopsinltransducin system (209). DeVries and co-workers isolated AGS3 in a yeast 
two-hybrid screen with Gia3 and characterized its properties using Biacore plasmon 
resonance and nucleotide binding assays (213). Simultaneous with the discovery that 
AGS3-GPR could inhibit GTPyS binding to Ga. subunits, Peterson discovered that a 
peptide derived from AGS3-GPRIV had the same effect (210). Subsequent studies 
demonstrated that the GPR peptide stabilized the GOP-bound state of Oa. in a "GDP-off' 
experiment and that the Ga. bound to AGS3-GPR contained GDP. In the same receptor 
reconstitution assays used in Figure 6.6, the GPR peptide was also effective in 
uncoupling receptors from G-proteins (210). Additional data about the GPR 
structuraVfunctional relationship has been obtained using a series of mutant GPRs. We 
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have also sent GST-GPR constructs to Dr. Stephen Sprang of the University of Texas 
Southwestern to initiate efforts to co-crystalize AGS3 with Ga. Currently, as part of our 
collaboration with Dr. Graber, the selectivity of individual GPR repeats to disrupt G-
protein heterotrimers and whether the repeats have differential effects on the formation of 
the high affinity state are currently being investigated. 
Through our efforts to characterize AGS3, a new Gn binding domain, the G-
protein regulatory domain, was defined. The results from this aim complete our 
characterization of the GPR as a Gia binding domain with guanine nucleotide 
dissociation inhibitory properties. The presence of the GPR in a protein not only 
suggests an interaction with GiaGDP, but also suggests that the protein is a 
heterotrimeric G-protein GDI. Recently, the Artemyev laboratory reported the effects of 
several GPR proteins on Ga guanine nucleotide binding (206). Each of the proteins 
tested (LON, Pcp-2 and RaplOap) was demonstrated to be a ODI. Their findings conflict 
with the report that Pcp-2 is a ODS, guanine nucleotide dissociation stimulator, for Ooa 
(152). The presence of a ODI domain in Gn GAPs ROS12 and RGS14 suggest that the 
two proteins may have unique influences on O-protein signaling. Through the GAP 
domain RGS12 and RGS14 could terminate a Ga signal, and through the GDI domain 
keep the Oa subunit from being re-incorporated into a heterotrimeric G-protein signaling 
cascade. A summary of the properties of GPR proteins is included in Table 6.1. 
AGS3 acting as a heterotrimeric G-protein GDI adds an unexpected dimension to 
field of G-protein signaling. AGS3 is also distinguished as a protein capable of 
dissociating heterotrimeric G-proteins without requiring nucleotide exchange. This 
activity likely accounts for the isolation of AGS3 as a G-protein activator in the yeast 
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Table 6.1. GPR Proteins 
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expression cloning system and may be suggestive of AGS3 function. AOS3 releases G~y 
from heterotrimers allowing it to activate the pheromone response pathway. In a similar 
manner, AGS3 may be a receptor independent activator of Ol3y pathways in mammalian 
signaling systems. However AGS3 is not a receptor independent activator of Gu 
subunits since it stabilizes the GDP-bound state of Gin, the inactive state. In addition 
Gin subunits bound to AGS3 cannot be recognized by G-protein coupled receptors. The 
overall effect of AGS3 IS to remove Ga subunits from their typical 
activation/deactivation cycle. The AGS3-GinGDP complex may therefore be a reservoir 
~. of Gin that can be tapped by GPy competition. In this capacity, AGS3 could desensitize 
G-protein signaling pathways at the level of G-proteins. An alternate role for the AGS3-
GiaGDP complex may be in heterotrimer-independent signaling systems. An unknown 
signaling regulator could stimulate nucleotide exchange selectively on the AGS3-Gia 
complex and couple the two proteins to unique effectors (Figure 6.7). In such a pathway, 
Ga. subunits could re-enter the normal G-protein cycle after termination of its signal. 
GPR containing proteins represent a class of heterotrimeric G-protein GDIs. The 
effects of these proteins reside in the newly described GPR domain. The AGS3 family is 
distinguished from other GPR proteins since its proteins contain multiple GPR domains. 
Since one of the repeats is capable of eliciting an effect, some questions arise regarding 
the presence of four repeats with presumably similar capabilities in one protein. Multiple 
GPRs may confer greater ODI activity to AOS3 compared with single OPR containing 
proteins. Alternatively, multiple GPRs may suggest a distinct role for the AGS3 family. 
AGS3 family members by binding to 3-4 Ou subunits could function to cluster Go. in 
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Figure 6.7 Functions of the AGS3·GiaGDP complex. The formation of AGS3-GiaGDP may have several consequences. 
AGS3 can remove GiaGDP from the G-protein activation/deactivation cycle by preventing it from interacting with G~y, and 
therefore receptor, thus causing desensitization at the level of G-proteins. AGS3- GiaGDP may also fonn as a means to affect 
the subcellular localization of Gia. AGS3- GiaGDP may be activated by undefined exchange factors, causing the formation of 
free AGS3 and GiaGTP possibly leading to the activation of unique effectors. 
scaffolding protein for Ga. Strengthening this hypothesis is the presence of conserved 
repeats in the N-terminus of AGS3 family members known to be involved in protein-
protein interactions, the TPR domain. 
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SPECIFIC AIM 4 
Determine the functional role of the AGS3 TPR region. 
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Introduction 
The discovery of Activator of G-protein Signaling 3 (AOS3) was the result of a 
long-term goal to identify G-protein regulators. AGS3 was first implicated as a Gn 
regulatory protein based upon the activity of the carboxyl terminal 74 amino acids in a 
functional screen designed to isolate receptor independent activators of G-protein 
.;\~~ signaling. AGS3-CT could activate the pheromone response pathway in yeast strains 
lacking the pheromone receptor. This activation was also independent of nucleotide 
exchange on the Gn subunit. Analysis of full-length AGS3 revealed the presence of 
distinct protein repeats in the N-terminus and C-terminus (Figure 1.10). The N-terminal 
repeats are tetratricopeptide repeats (TPRs), degenerate domains involved in protein-
protein interactions. The C-terminus of AGS3 contains four GPR or GoLoco repeats 
which have been sho.wn to bind to and stabilize the GOP-bound form of Gia subunits. In 
addition, the GPR domain dissociated Gn from GJ3y and thus was thought to be 
responsible for G-protein activation in the Saccharomyces cerevisiae expression cloning 
system. The N-terminal TPRs and C-terminal GPRs are connected by a 100 amino acid 
linker sequence with little homology to proteins in the GenBank database. 
Although function has been ascribed to the C-terminus of AGS3 little is known 
about the function of the TPR and linker domains of AGS3. TPRs, or TetratricoPeptide 
Repeats, are 34 amino acid repeats of which only eight residues are conserved. Therfore, 
there exists a high degree of variability in function among TPR containing proteins. 
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TPRs are detected in over 450 proteins from bacteria to humans and function in various 
cellular roles (154). The TPR domain in the AGS3 D. melanogaster homolog PINS is 
responsible for interacting with Inscuteable (155 Yu, 2000 #368); however there is no 
homolog of Inscuteable yet detected in either the C. elegans genome or in mammalian 
genomes. PINS binds to a region of five ankyrin-like repeats in the Inscuteable sequence 
which do not generate database hits when used in BLAST searches. Through this 
interaction, PINS gets recruited to apical membranes where it helps to stabilize the 
polarity/asymmetry complex. Outside the AGS3 family, the TPR structure of AGS3 is 
most closely matched by rapsyn- receptor associated protein of the synapse (Figure 7.1). 
Nicotinic acetylcholine receptors in rapsyn knockout mice fail to cluster at post-synaptic 
membranes (216). The receptor binding domain of rapsyn was localized to the C-
terminus and the portion responsible for cluster receptors was found to be the TPR region 
(189). Although not yet demonstrated, rapsyn is suggested to interact with dystrophin at 
post-synaptic membranes to anchor its clusters (217). In both PINS and Rapsyn, the TPR 
domains were involved in sub-cellular localization. Our hypothesis was that the TPR 
domain served as regulatory domain for AGS3 by influencing its sub-cellular 
localization. Since no binding partners of the AGS3TPR domain have yet been detected, 
we performed a yeast two-hybrid screen using an N-terminal AGS3 construct as bait. 
The focus of this aim was the screening of a mammalian cDNA library and identification 
of candidate TPR binding partners. 
With advice from Dr. Tim McQuinn and Mary Cismowski, we decided to use 
Clontech Pretransformed Matchmaker Libraries as our source of prey sequences. In 
















Figure 7.1 TPR domains of AGS3 and related proteins. The domain structure of AGS3, PINS and rapsyn are schematically 
depicted. Black boxes- TPR; Gray Boxes- GPR; nAR-BD- nicotininc Acetylcholine receptor binding domain. Underneath the 
TPR domains are their functions and binding partners. 
utilize mating of two haploid strains to generate yeast strains expressing both bait and 
prey proteins (Figure 7.2). A positive interaction between bait and prey proteins induces 
the expression of up to four reporter genes, two of which are nutritional. Two additional 
nutritional markers are incorporated in plasmids of both bait and prey. One of the 
inducible reporter genes is LacZ affording the use of various f3-Galactosidase assays. To 
initiate two-hybrid screening, our task was to generate bait strains and verify that they did 
not cause basal activation of reporter genes. These strains would then be used to screen 
mammalian cDNA libraries for candidate positive interacting proteins. Candidate clones 
isolated by selection and/or reporter gene assays would be isolated and re-transformed to 
confirm their activity. Using sequence analysis, positive clones could be restricted for 
those clones that were in the proper open reading frame with respect to the prey vector. 
This pool could also be narrowed by eliminating DNA binding proteins and extracellular 
matrix proteins whose distribution is strictly outside the cell. From this analysis we 
sought to identify candidate clones with which to further our studies with AGS3. The 
first steps in characterizing these clones would be to perform interaction assays outside of 
the yeast system to confirm the association between the clones and AGS3. 
Results 
Generation and characterization of bait strains. 
Two N-terminal domains were used in two-hybrid screerung experiments: 
TPRLong (TPRL) and TPRShort (TPRS) (Figure 7.3A). AGS3-TPRL (M1-1462) 
contains the TPR domain and the linker region whereas TPRS (M1-G337) contains only 
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Figure 7.2 Yeast two-hybrid screens. Positive protein-protein interactions can be detected by nutritional selection as shown in 
the cartoon. Yeast expressing two hybrid proteins, Gal4AD-prey (cDNA library) and Gal4BD-bait (AGS3-TPR), can be 
selected by TRP- and LEU- selection. Positive interactions between the hybrid proteins induce the expression of reporter genes 
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Figure 7.3 Analysis of AGS3-TPR bait strains. A) AGS3 fragments used as bait in the yeast two-hybrid screen: TPRL- Ml-
1462, TPRS- MI-G337. B) Y187 " and AHI09 yeast strains containing empty vector, TPRL, TPRS and p53 (bait positive 
control) were plated onto selective media indicating the uptake of plasmid (SD -TRP). After 3 days growth 5 colonies were 
picked from each plate and re-streaked upon various selective media: SD-TRP, SD -LEU, SD -ADE, SD -HIS. Pictures were 
taken after 3 days growth. Shown are representative plates. Small spots indicate pen marking to indicate the location of colony 
streaks. 
transformed into yeast strain AHI09 to generate bait strains. In our initial analysis, the 
constructs were also transformed into the Y187 strain. Non-transformed yeast and yeast 
transformed with empty vector, TPRL and TPRS were plated onto selective media 
(Figure 7.3D). Growth was only detected on SD -rrp plates as expected. Compared 
with a positive control, no basal LacZ activity was detected. To verify if the TPR 
constructs were expressed, protein extracts from AHI09-TPR strains were obtained and 
analyzed by immunoblotting. Proteins migrating at the appropriate molecular weight 
were detected by a monoclonal Anti-myc antibody (data not shown). These data 
confirmed that AGS3-TPR did not basally activate reporter gene expression in the 
matchmaker system and that the AGS3-TPR fusion protein was expressed in the bait 
strains. 
Screen mammalian libraries for AGS3-TPR binding partners. 
We performed three yeast two-hybrid screens with the AGS3-TPRL as bait. The 
first two screens were of a rat brain cDNA library; a mouse 11 day-old embryonic cDNA 
library was used in the third screen. Although the first screen was a technical disaster, we 
learned enough from our mistakes to perform the second screen with sufficient expertise. 
The results from the first two screens are not included. The focus of this chapter will be 
on the results of the third screen. Despite the lack of evidence demonstrating expression 
of AGS3 in mammalian embryos, the series of reports about PINS suggested that an 
AGS3-TPR binding partner might be found in embryonic libraries. Each screen utilized 
the same mating protocol, but the method to identify candidate clones differed. In the 
first screen the mating culture was initially plated upon TDO (triple dropout: ""Trp, -Leu, -
128 
His) media, and candidate clones were selected by selective growth on QDO (quadruple 
dropout: lrp, -Leu, -His, -Ade) media. In the second and third screens, initial plating was 
upon QDO media and selection of candidate clones was achieved by f3-Gal assays 
(Figure 7.4). Yeast plasmids from positive colonies were isolated and transfonned into 
bacteria to amplify the plasmids for sequencing and retransfonnation. Sequence analysis 
of each screen is listed in Appendix A. A summary of the candidate clones isolated from 
each screen and the method used in each screen are listed in Table 7.1. 
c:,:,~ Identify potential N-terminal regulatory partners of AGS3. 
A yeast two-hybrid screen of a mouse II-day old embryonic library using AOS3-
TPRL (MI-1462) as bait yielded the identification of several AGS3 binding partners. 
Four of these proteins are involved in aspects of asymmetric division and/or cell polarity 
and were therefore became the focus of our efforts. The candidate TPR binding partners 
are MACF- microtubule actin crosslinking factor, MRP- MARCKS related protein, 
SrrKl1- Serineffhreonine Kinase 11 and the mouse homolog of Robo. Due to various 
circumstances each candidate did not receive equal attention. In the last few months of 
my laboratory work I focus~d upon SffKll and that work is described below. Before the 
studies with StrKll are addressed, I will describe what is known about the three other 
candidate proteins. 
MACF- Microtubule Actin Crosslinking Factor 
MACF is a member of a recently recognized family of giant cytoskeletal 
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Figure 7.4 Selection of positive clones. The mating c~lture ' was plated upon 120 QDO 
plates· . . Ten colonies from each plate were selected and re-streaked onto QDO plates after 3 
days of. growth . . Colony lift B-Gal assays resulted in 120 positive clones (10%) . . The ·120 
colonies were re-streaked onto QDO plates (max 25 colonies per plate ) and allowed to grow 
for 3 days. Colony lift assays on the 120 colonies resulted in the identification' of 16 colonies 
that displayed strong B·-gal activity. Yeast plasmids were isola~ed from culture of the 16 
positive clones and transfo.rmed in chemically competent KC-8 cells for amplification and 
sequencing. Each positive clone was re-introduced into yeast strains to verify activity. 13 out 









































acid protein with N-terminal actin binding domains, a microtubule binding domain, 
twenty-three dystrophin-like spectrin domains, a calcium binding EF-hand repeat and 
another microtubule binding domain related to Gas2 (Figure 7.5). MACF has related 
proteins in the fruit fly genome collectively known as kakapo. The region of MACF 
isolated in the two-hybrid screen (3560-4160) encompasses 5 dystrophin-like spectrin 
repeats. MACF and kakapo direct microtubule formation from integrin-rich sites at cell-
cell boundaries and regulate the actin-microtubule interface (219, 220). Kakapo, named 
for a wingless parrot, was discovered as a protein important for wing formation in D. 
melanogaster (221). Kakapo was also isolated as a gene important for dendritic 
outgrowth and branching of developing neurons (222). Kakapo has been reported as 
short stop since axons fail to grow to normal lengths in short stop mutant flies (223). 
MRP- MARCKS Related Protein 
MRP is a distant relative of MARCKS (Myristolated Alanine-Rich protein Kinase 
C Substrate) sharing the N-terminal myristolation site, a MARCKS homology 2 (MH2) 
site and a PKC sensitive CalCalmodulin binding site that also binds to actin (Figure 7.5) 
(224, 225). MRP is also known as MacMARCKS and MLP (MARCKS-Like Protein) in 
the Genbank database and in the literature. As yet, no homologs or MRP or MARCKS 
have been detected in lower organisms. Of the 204 total amino acids, the fragment 
isolated in two-hybrid screening represents the last 175 amino acids of MRP containing 
most of the functional domains except for the myristolation site at the N-terminus. MRP 
is involved in general aspects of cell trafficking and morphogenesis during embryonic 
development likely through its binding to and regulation of phospholipid vesicles (226, 
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Figure 7.5 Yeast two-hybrid positive candidates. Schematics of whole proteins whose fragments were isolated in the two-hybrid 
screen include protein domains as predicted from database searches and from publications. Underneath each protein is the region 
isolated in the screen. Protein domains, amino acid length and other pertinent information are included. Protein domain 
abbreviations are as follows: AD- actin binding domain, CAAX - C-terminal fatty acid modification site, ED- effector domain (ac tin 
binding), FN3- fibronectin domain type 3, IG- Immunoglobulin domain, IF, intermediate filament binding domain, MH2- MARCKS 
homology domain 2, MT - microtubule binding domain, Myr- N-terminal site of myristolation, P- PKC phosphorylation sites, grey 
bar- calcium binding domain, black bar- transmembrane domain. 
is found basally localized in the neuro-epithelium. :MRP knockout mice fail to obtain 
proper cranial neurulation likely through abnormal cell morphogenesis during neural tube 
formation (228). Basal localization is mediated through a PKC dependent mechanism 
and involves the actin binding domain in the C-terminus (229, 230). 
Robo 
Another positive clone represented the mouse homolog of the D. melanogaster 
protein roundabout, or robo (231, 232). Robo regulates crossing of the CNS midline by 
growing axons (231-234). Mammalian family members of robo have been reported in 
the literature with similar function (235, 236). The C. elegans homolog, sax-3, has been 
implicated in axon growth, guidance and maintanence in the developing nervous system 
(237). Robo contains several IG-like domains in its extracellular N-terminus, a single 
membrane span region and a cytoplasmic tail of roughly 400 amino acids. The fragment 
of mRobo obtained in the screen represents the C-terminal 406 amino acids comprising 
of the entire predicted cytoplasmic domain (Figure 7.5). Robo is a cell surface receptor 
for the midline repellant Slit (238). In Robo mutants, axons that normally cross the CNS 
midline once are found to cross numerous times (239). Robo is enriched in growth cones 
during axon guidance and is up-regulated after axons cross the midline (234). While the 
ligand for Robo is known, the downstream signaling events have not been characterized. 
StrKll 
One of the candidate clones contained the coding region of the C-terminal 107 
amino acids of serine/threonine kinase 11 (SfTKl1). StrKl1, also known as LKB 1, is a 
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product of a gene implicated in Peutz-Jeghers Syndrome, a condition manifested by 
neoplasia of the GI tract (240). Mutations in SfTKl1 that inactivate the kinase domain 
lead to increased risk of GI tract cancer suggesting a potential role as a tumor suppressor 
(240, 241). The only identified protein domains in SffKll are the 180 amino acid kinase 
domain (K44-P314) and a C-tenninal CAAX box, a site for fatty acid modification 
(Figure 7.5). The region of SITKII interacting with AGS3 has no function ascribed to it, 
yet it is -90% conserved between mouse and human. StrKl1 is also the mammalian 
counterpart to the partitioning defect gene, Par-4, in C. elegans (242). Par-4 was 
discovered in a genetic screen looking for improper partitioning of cytoplasm of the one-
cell stage of C. elegans embryos (177). Par-4 knockouts were initially reported to 
generate arrest in early stages of development and to prevent the start of intestinal 
development (243). Par-4 was recently identified as a serine/threonine kinase that directs 
the proper localization of asymmetry determinants par-3 and par-6 in the one-cell stage of 
C. elegans embryos (179, 242). 
Re-screening of SffK11 and AGS3 constructs TPRL (MI-I462) and TPRS (Ml-
0337) using the two-hybrid method revealed selective binding of StrKll to AGS3-
TPRL (Figure 7.6). Compared to TPRS, TPRL contains an additional -120 amino acid 
region that links the N-terminal TPR domains to the C-terminal OPR domains. This 
domain is conserved between mice and humans, however it is not conserved in AGS3 
family member LON nor is it conserved in AOS3 homologs in lower species. There are 
no predicted protein domains or consensus phosphorylation sites within the linker region. 
The bait construct TRPL does contain a consensus tyrosine kinase phosphorylation site 
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Figure 7.6 Secondary screen of StrKll and MACF. Prey plasmids bearing clones 15B (MACF) and 741 (STKll) were co-
transfected into yeast strain AHI09 with empty vector, TPRL and TPRS. Transformants selected upon SD -TRP, -LEU plates 
were re-streaked onto QDO plates and allowed to grow for 3 days. If present, yeast growth spots were analyzed for (i-gal by 
colony lift assay. Plus (+) indicated selective growth on QDO plates and positive LacZ activity. Minus (-) indicates no growth 
onto selecti ve media~ 
Confirm interaction of AGS3 with potential binding partners. 
To verify the interaction of SrrKll with AGS3, in vitro protein-protein 
interaction studies were perfonned. GST -SrrKII (D330-Q436) was able to pull down 
endogenous, full length AGS3 out of a rat brain lysate treated with either GDP or GTPyS 
(Figure 7.7). Previous data indicate that AGS3 and Gin can exist in a protein complex, 
therefore protein complexes were also probed for the presence of Gin subunits. Indeed, 
Gin was present in protein complexes isolated from GDP-treated lysates, but not in 
protein complexes isolated from GTPyS treated lysates. The selective presence of Gin in 
GDP treated but not GTPyS treated lysates mirrors previous observations that the 
interaction between AGS3 and Gia is enhanced in the presence of GDP. 
Discussion 
Using an II-day old mouse embryo library as prey we isolated several clones, one 
of which corresponded to the carboxyl terminal 107 amino acids of serine/threonine 
kinase 11 (SffKll). Other proteins isolated in two-hybrid screening with AGS3-TPRL 
are involved in aspects of cell polarity/asymmetry. SrrKll, also known as LKBI 
(LKBl), is implicated in Puetz-Jeghers Syndrome, a condition characterized by 
neoplasms of the GI tract. The downstream targets of SffKll kinase activity have yet to 
be identified. SlrKl1 is also the mammalian counterpart of the C. elegans gene Par-4, a 
member of a group of genes that display partitioning defects in early embryogenesis 
when mutated. The region of SrrKl1 isolated in the two-hybrid screen begins just after 
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Figure 7.7 Interaction of SffKll with AGS3. Rat brain (2 mg) lysates were preincubated with 30 nM GDP or 30 nM 
GTPyS/25 mM MgCl2 at 24°C for 30 minutes. Lysates were then incubated with 500 nM GST or GST -STK11(330-436) for one 
hour at room temperature. Protein complexes captured by glutathione sepharose beads were analyzed by immunblotting. 
Membrane transfers were first blotted with AGS3 P-32 antisera and then stripped and with Gia antisera. The data are 
representative of2 experiments. The input lane contains 1/10 of the lysate volume used for each interaction assay. 
hybrid analysis, the C-terminal fragment of SffKll interacted with an AGS3 fragment 
containing the TPR domain and the linker, but it did not interact with the AGS3-TPR 
region alone. When generated as a GST fusion protein, the SffKll CT was able to pull 
down AGS3 from rat brain lysate. Also present in this complex was Gia; subunits; 
however Gia; was only present in protein complexes captured from GDP versus GTPflyS 
treated 1 ysates. 
The results of two-hybrid screens described in this aIm have identified four 
candidate proteins that bind to the N-terminal TPRs of AGS3. The data concerning the 
interaction of AGS3 with SffKll serve as the foundation of a manuscript being prepared 
for submission. Currently, Blumer working in Dr. Lanier's laboratory at the LSD Health 
Science Center is continuing the work with the candidate interacting proteins. If a 
functional association between AGS3 and SffKll can be demonstrated, it would be the 
first such finding that a mammalian AGS3 family member is linked to a determinent of 
cell polarity. Also, Dr. Lanier's laboratory is in the early stages of establishing 
collaborations with laboratories that work on MACF, MRP and Robo. Each of these 
proteins deserves their due attention as possible AGS3 interacting proteins (Figure 7.8). 
AGS3 contains two distinct protein repeat domains; N-terminal Tetratrico-Peptide 
Repeats (TPRs) and C-terminal G-Protein Regulatory (GPR) repeats. The TPR domain is 
thought to serve a regulatory role in AGS3 function while the GPR domain serves a 
catalytic role by activating G-proteins. It is unclear if the GPR domain affects the 
activity of the TPR domain; however the TPR does not affect the ability of the GPR to 
interact with Ga; subunits. Based on studies with the AGS3 homolog in D. melanogaster 
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. Figure 7.8. Roles ofye.ast two-hybrid hits in neural development. Functions of yeas~ two-hybrid hits are s1;lo~n with respect 
to the polarity/asymmetry complex. 
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Inscuteable (155, 156). PINS translocates to apical membranes of neuroblasts as they 
delaminate from the neuro-epithelium. At the apical membrane, PINS forms a complex 
with Inscuteable, Bazooka, dPar-6 and daPKC3 (244). The translocation of PINS and the 
maintenance of PINS in that complex might be independent (173). Modification of 
AGS3 once it arrives at the apical membrane may anchor it in the complex until the 
neuroblast divides and the complex dissolves. SffK11 homolog Par-4 has been 
demonstrated to direct the localization of asymmetry-determining proteins in C. elegan~ 
(179). Worms expressing mutated forms of par-4 exhibit wide distributions of par-3 
(homolog of Bazooka) and par-6 (homolog of DmPar-6) at the membrane distinct from 
the specific localization found in wild type worms. The interaction of AGS3 with 




SPECIFIC AIM 5 
Determine the function of AGS3 in the intact organism. 
142 
Introduction 
At the inception of this project, the functional role of the AGS3 family was 
unclear. Most of the work on AGS3 family members at that point had focused upon the 
I 
Gu binding domains in the C-terminus. An obvious question at the time concerned the 
functional role of AGS3 and if AGS3 influenced G-protein signaling pathways. In 1998, 
{~~ Fire developed a technique known as RNA interlerence that could quickly generate 
knockout animals in the nematode C. elegans (190). Database searches indicated that the 
AGS3 family had a member in the C. elegans genome containing five N-terminal TPRs 
and four C-terminal GPRs. Overall homology between this protein and AGS3 was -42% 
with most of the similarity in the GPR domain and to a lesser degree in the TPR domain 
(Figure 8.1). After talking with several C. elegans researchers, we set up a collaboration 
with Dr. Guy Benian of Emory University in Atlanta, GA. With Dr. Benian's help we 
sought to generate RNA interference (RNAi) knockouts of the AGS3 homolog in C. 
elegans, AGS3-CE. Simultaneously, we sought to map the distribution of AGS3-CE in 
the whole animal. This chapter describes our efforts to obtain preliminary data 
concerning the function of AGS3-CE in the intact animal. 
In 1998 the genome of C. elegans was completed and made public thus 
representing the first finished genome of a multicellular organism (245). The release of 
this data allowed us to analyze the gene structure of AGS3-CE and use it for our 
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Figure 8.1 Comparison of the AGS3 and AGS3-CE protein domains. AGS3 and AGS33-CE domains are indicated as 
follows: Black (TPR); Gray (GPR). The predicted homolog of AGS3 was detected by BLAST searches as U40409. AGS3-CE 
was the fourth gene contained on cosmid F32A6, thus it is also referred to as F32A6.4. Five entries into the est database of Yuji 
Kohara (DNA database of Japan, www.ddbj.nig.ac.jp) contain the full length coding region of AGS3-CE: yk283d6, yk391f5, 
yk404g12,yk432h7,yk469f8. 
gene could be mapped out with the use of reporter genes. With vectors made available 
by the Fire lab, we could generate these constructs and use them in expression mapping 
experiments. Dr. Benian provided us with both reporter vector (pD96.04) and genomic 
DNA from which to begin our studies. Our role was to make the constructs and bring 
them to his laboratory to perform the microinjections. 
RNAi is a method by which double stranded RNA of a coding region can repress 
the protein expression of the encoded protein (190). Injection of dsRNA into the gonad 
syncytia of a subadult worm results in the birth of a whole generation of knockout 
animals. The effect is highly penetrant and is relatively expedient compared with other 
knockout techniques (246, 247). RNAi can be easily duplicated and controled. We 
obtained the AGS3-CE cDNA from the est repository of the DNA Databank of Japan 
(www.ddbj.nig.ac.jp). We manipulated this cDNA to make several RNAi templates. 
Double stranded RNA was produced in our laboratory and brought to the lab of Dr. 
Benian where the injections occurred. We hypothesized that AGS3-CE RNAi worms 
would show phenotypes similar to those observed in G-protein mutants. G-protein 
function in C. elegans had been well documented and numerous genetic studies had been 
reported (33, 55, 188). 
Results 
Determine the tissue distribution of AGS3-CE in C. elegans. 
Using genomic sequence information, PCR primers were designed to amplify 
I 
regions of the AGS3-CE gene. Five prime primers, containing a Hind III site, were 
positioned roughly 3 kb upstream of the start methionine of AGS3-CE. Three prime 
primers, positioned in the second ex on of AGS3-CE, contained a BamHI site engineered 
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to maintain the open reading frame of AGS3-CE and the coding regions of LacZ: :GFP in 
the pD96.04 vector (Figure 8.2). PCR fragments were subcloned into the Hind III and 
Bam III sites of pD96.04 and plasmid DNA was amplified in bacteria. 
Sub-adult worms were co-injected with pD96.04-AGS3-CE promoter and a 
marker gene, rol-6. Uptake of the rol-6 marker is characterized by abnormal "rolling" 
motion and movement in circular patterns. Of over 40 worms injected with the AGS3-
CE promoter recombinant DNA, eleven of their progeny were detected that displayed the 
roller phenotype. Progeny of injected wonns displaying the "roller" phenotype were 
~~~ analyzed for LacZ and GFP expression. One adult worm exhibited GFP expression in the 
chemosensory area near the head. The other ten did not display any GFP expression. In 
adult worms, staining with X-gal revealed a consistent pattern of staining to that observed 
in the GFP expressing worm (Figure 8.3A). Several sub-adults showed staining in the 
chemosensory region and additional staining down the body of the worms (Figure 8.3B). 
The pattern of expression is consistent with the C. elegans nervous system. 
Define the knockout phenotype of AGS3 homolog AGS3-CE in C. elegans. 
Double stranded RNA generated from an AGS3-CE full-length template was used 
to generate RNAi worms. Injection of two sets of worms with AGS3-CE full-length 
dsRNA gave vastly different results. A set of worms very close to adulthood did not give 
birth to progeny displaying any noticeable RNAi phenotype. However a set of worms at 
a more optimal stage for microinjection gave birth to a generation of progeny displaying 
a distinct phenotype. AGS3-CE RNAi worms were arrested at a very early stage of 
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-Figure 8.2 Subcioning of the AGS3-CE promoter. PCR primers Were designed to obtain the 3 kb region upstream of the start 
methionine of _AGS3-CE in addition to the frrst exon, first intron and part of the second -exon. Three priine primers were made 






Figure 8.3 Expression of AGS3 in the adult and sub adult Transgenic worms displaying the roller phenotype were stained for 
the expres·sion of LacZ as described in the methods section. LacZ staining of A) an adult and B) a subadult worm containing the 
AGS3 promoter-LacZ fusion vector. The adult worm (only head shown) is representative . of 7 such worms out a total of 11 
rollers. The . sub adult (head-tail:right-Ieft) is representative of 2 such worms. Images were taken . with a camera mounted light 
microscope (40X power). 
~t;J 
distribution. This effect was highly penetrant, displayed In over 80% of the Fl 
generation (Table 8.1). 
Discussion 
AGS3-CE constructs for expresslon mapping studies and RNA interference 
experiments were generated. AGS3-CE promoter constructs were injected into sub-adult 
worms resulting in a somewhat similar staining in eleven worms. The expression profile 
was consistent with that of the C. elegans nervous system. Although the sample size was 
small, there was the indication that the expression of AGS3-CE is developmentally 
regulated. Staining patterns in younger worms were stronger than that observed in adult 
worms. Adult worms consistently displayed expression of AGS3-CE in the 
chemosensory neurons. AGS3-CE RNAi worms were arrested at a very early stage of 
embryogenesis, possibly in the one-cell stage, and were unusually clustered. Each 
embryo was of similar size in the groups of 4-12. The RNAi phenotype was highly 
penetrant. 
The preliminary microinjection experiments discussed in this aim were conducted 
over the span of one week in the laboratory of Guy Benian at Emory University. During 
this time, we were able to map the expression of AGS3-CE and generate a RNAi 
phenotype. Unfortunately, we were not able to continue our collaboration after the initial 
experiments were performed. Regardless, these experiments serve as a foundation for 
future studies with AGS3-CE. We have sent our materials to the laboratory of Dr. Ohno 







1 21/25 84% 
2 48/51 95% 
3 43/53 81% 
4 13/17 76% 
5 26/31 84% 
6 28/35 80% 
7 6/14 43% 
8 55158 95% 
9 18/19 95% 
10 45/45 100% 
11 53/68 78% 
12 12125 48% 
13 35/46 76% 
14 34/34 100% 
15 41/44 93% 
Total 478/565 84.6% 
Table 8.1 Analysis of AGS3-CE RNAi phenotype. Raw numbers and percentages of worms displaying the AOS3-CE RNAi 
phenotype as displayed. Individual zygotes were counted, not zygote clusters. 
The studies with AGS3-CE were conducted just prior to the discovery of PINS in 
the fruit fly. With the additional flurry of reports about the polarity/asymmetry complex, 
our AGS3-CE data need to be re-examined (Figure 1.11). If the protein complex used for 
'establishing polarity or generating asymmetry is conserved from the nematode one-cell 
stage to the fly neuroblast, our AGS3-CE RNAi results may have merit. Members of the 
polarity/asymmetry complex PKC3 and Par-6 have a similar RNAi phenotype, embryos 
in an amorphous cell mass (179). If we discount that AGS3-CE RNAi zygotes were 
clustered, and re-interpret them as the results of abnormal embryonic division the AGS3-
CE RNAi phenotype is consistent with that of other polarity determinants. A recently 
published manuscript implicated both Ga and GJ3 in the proper divisions of early 
embryos, supporting the case that a heterotrimeric G-protein regulator is involved in 
these processes (55). The authors concluded that the liberation of GJ3y is the primary 
trigger of spindle rotation and asymmetric cell division. Release of GJ3y is the 
mechanism by which AGS3 activates G-proteins in mammalian systems. Expression of 
AGS3-CE in the nervous system of C. elegans is consistent with expression patterns 
observed across species. The apparent increase of expression in development correlates 
with studies in the developing fly, in which PINS expression is highest during the early 
stages of development (156). 
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CHAPTER 9 
DISSCUSSION AND CONCLUSIONS 
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AGS3 was discovered as part of an effort to identify novel G-protein regulators. 
Through biochemical, genetic and functional assays the work presented in this 
dissertation has characterized the properties of AGS3 and has laid the ground work for 
future discoveries. AOS3 interacted with On subunits through its C-terminal GPR 
domain, a novel signature motif for G-protein interacting proteins. This interaction is 
specific for the Gia family, and AGS3 seems to prefer the GDP bound state of Gin 
subunits. Through its multiple GPR domains, AGS3 binds to as many as four On 
subunits simultaneously. While bound to AGS3, Gn subunits neither undergo nucleotide 
exchange nor can they be recognized by G-protein coupled receptors. AGS3 activity in 
the original yeast expression cloning system can be explained by its ability to compete 
with G(3y for binding to GaGDP. The N-terrninus of AGS3 contributes to overall 
function by its possible interactions with several proteins known to playa role in neural 
development. AGS3 interacts with STKl1, the mouse homolog of a polarity detenninant 
in C. elegans. When we knock out the AGS3 homolog in C. elegans, we generate a 
phenotype not inconsistent with those observed with other polarity/asymmetry 
determinants. 
AGS3 as an activator 
The yeast expression cloning system used to isolate AGS3 was orignially 
designed to clone the NO-108 activator, a GnGEF. AGS3 was discounted as a GEF 
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since its activity did not require the fonnation of GaGTP. Further biochemical analysis 
of AGS3 indicated that AGS3 actually stabilized the GDP-bound, or inactive, form of 
Ga. Regardless, AGS3 was named an activator of G-protein signaling since it could 
stimulate the Gpy-mediated pheromone response pathway. In mammalian systems, both 
Go. and G~y can transduce signals. Thus, we are presented with a paradox. AGS3 
stabilizes the inactive form of Gia subunits and liberates a Gf3y molecule. By disrupting 
heterotrimer formation AGS3 is also preventing receptor access to G-proteins thereby 
uncoupling Gia signaling from external stimuli. AGS3 is therefore acting more as an 
",C activator of GPY signaling than of G-protein signaling. This assumes that AGS3 is 
disrupting heterotrimers and not finding free GaGDP subunits. The physiological 
consequences of AGS3 activity would be selective activation of GPy signaling not 
initiated by a receptor. This raises the interesting possibility of GPy released by AGS3 
behaving differently than GPy released by receptor-mediated activation of Ga. 
AGS3 as an accessory protein 
Accessory proteins are defined as proteins that can 1) regulate the transfer of 
signal from receptor to G-protein to effector or 2) regulate the activation-state of G-
proteins independent of receptor stimulation. AGS3 was identified as a G-protein 
activator in a genetic screen, but as mentioned above has some unique mechanisms of 
activation. AGS3 does meet the definitions of an accessory protein because it regulates 
the transfer of signal from receptor to G-proteins (Figure 6.6), and influences the 
activation-state of G-proteins independent of receptor (Figure 6.5). What has yet to be 
determined is whether AGS3 has these capabilities in the context of mammalian G-
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protein signaling. What makes AGS3 unique among the class of G-protein regulators is 
the presence of multiple Ga binding sites. Most G-protein regulators, such as the RGS 
family of GAPs, contain one domain capable of influencing Ga activity. AGS3 with its 
four GPRs may also be included in another class of accessory proteins, the scaffolding 
proteins. By interacting with multiple Ga subunits, AGS3 might function either to 
seqeuster G-proteins or to localize them to distinct cellular sub-domains. If AGS3 TPRs 
can self-associate as do the Rapsyn TPRs, then AGS3 could effectively cluster GaGDP 
subunits (248). Alternatively, the role of AGS3 may be to regulate the pool of GaGDP 
available for receptor coupled signaling. Thus, AGS3 could cause desensitization of 
GPCR signaling at the level of G-proteins. 
At this point, little is known about the circumstances necessary for AGS3 to 
engage G-proteins. Most of our sub-cellular fractionation and immunohistochemistry 
data indicate that AGS3 is localized to the cytosol (198). In rat brain AGS3 is found in 
the 100,000 x g supernatant which agrees with the pattern of immunohistochemical 
staining observed in primary cultures of hippocampal neurons (J. Blumer unpublished 
observations). Therefore, AGS3 must either translocate to the membrane, or interact with 
GiaGDP in the cytosol, to regulate G-protein activity. The former is the most likely the 
mechanism given the dynamic localization of PINS in neuroblasts. PINS is cytosolically 
distributed until the neuroblast begins its delamination, when AGS3 is recruited to apical 
membranes (155, 156). This localization is thought to require a protein-protein 
interaction between Inscuteable and the TPR domain of PINS. If PINS function is 
conserved, then AGS3 would be translocated to the membrane via its TPR domain, a 
likely candidate for such a function. If AGS3 is acting outside of a developmental role 
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then its activity might be regulated by signaling events. RGS proteins are translocated to 
the membrane after a signaling stimulus (249), and in yeast have been implicated in a 
negative feedback loop (250). AGS3 could alternatively be activated by a non-GPCR 
signal to stimulate the selective release of G~y. Such non-traditional signal crosstalk has 
been reported. IGFII receptor immunoprecipitation complexes contain Gi heterotrimers, 
but upon receptor activation GPy is absent from these protein complexes (251, 252). 
AGS3, outside the R-G-E paradigm 
,,;: Heterotrimeric G-protein activity is positively regulated by GEFs and negatively 
regulated by GAPs. However, both types of regulators propel the G-protein 
activation/deactivation cycle in the same direction (Figure 6.7). AGS3 is unique among 
these proteins in that it can disrupt the normal progression of G-proteins through their 
usual stages of activation. By preventing heterotrimer formation, AGS3 stimulates Gf3y 
mediated signaling but keeps Oa dormant. The function of the AGS3-GiaGDP complex 
may be to allow for a temporary burst of free GJ3y. However, AOS3 may function as an 
alternate signaling binding partner for GiaGDP. Therefore AGS3-GiaGDP could be 
considered a heterodimer under control of unique regulators that acts upon unique 
effectors. In such a scenario, activation of the AOS3-GiaGDP complex would require an 
exchange factor distinct from G-protein coupled receptors. Activated Ga subunits would 
undergo hydrolysis of GTP to terminate their signals and regenerate GaGDP. At that 
stage, GaGDP could either enter the normal cycle, or enter a heterotrimer-independent 
signaling pathway by partnering with AGS3. 
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The AGS3-GiaGDP complex has the p~tential to self-aggregate or to localize to 
-
unique regions of the cell. AGS3 can potentially bind up to four Gn subunits at a time 
through the GPR domain suggesting a role as a scaffolding protein. H the TPR domain 
dictates the localization of AGS3, then the domain also dictates where Ga subunits are 
localized. The binding and subsequent concentration of GaGDP might be involved in G-
protein oligomerization. Rodbell hypothesized that G-proteins, especially the Go. 
subunit, evolved from cytoskeletal origins (62). Also, in contrast to crystallization of the 
GTPyS bound On subunit, GaGDP crystals tend to form oligomers with much higher 
frequency (253). As mentioned above, the clustering of GiaGDP might also playa role 
in regulating the pool of available OiaGDP. However, in the context of asymmetric 
division, sequestration of Gia to one pole of a dividing cell could have a significant 
effect upon the fates of the daughter cells. Given the selectivity of AGS3 for Gia versus 
Goa, the apical daughter cell of an asymmetric neuroblast division would receive more 
Gin than its basal counterpart. This postulation is premature, since the identity of the G-
protein found in the INSCIPINS complex is currently unclear (155). 
Function of AGS3 in development 
The fly counterpart of AGS3, PINS, is a critical determinant of neuroblast cell 
polarity, spindle rotation and asymmetric division. PINS is but one of a handful of 
proteins implicated as required components of an apically localized complex in the 
neuroblast. Looking across species, homologs of some of the required proteins have been 
suggested to play similar roles but in other cell types (Figure 1.11). Asi.de from PINS, 
there are no reports of other AGS3 family members being directly linked to 
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corresponding protein complexes in mammalian cells. Our preliminary data indicate that 
AGS3-CE might be involved in aspects of early embryogenesis. The discovery of the 
Par-4 homolog, SrrKll, in a yeast two-hybrid screen suggests that AGS3 is linked to the 
polarity/asymmetry complex in mammalian systems. AGS3 is highly expressed in brain, 
but we do not know if its expression is developmentally regulated or if AGS3 is 
expressed in mammalian neuroblasts. A critical future study would be to localize AGS3 
with mammalian counterparts of the polarity/asymmetry complexat apical membranes in 
developing mammalian neuroblasts. 
In my view, the purpose of PINS in the polarity/asymmetry complex has yet to be 
completely determined. Each manuscript reporting the discovery of PINS concluded that 
PINS is required to maintain the apical complex after it arrives via its interaction with 
Inscuteable. However, only one paper commented upon the potential of a G-protein 
signaling event emanating from the complex (155). PINS is apparently tethered to the 
polarity/asymmetry complex via an interaction with Inscuteable (156). While the TPR 
domain mediates this interaction, the GPR domains interact with Gi/oa (155). With our 
demonstration that the AGS3-GPR domain can dissociate heterotrimer and therefore 
liberate Gf3y, the function of PINS may be to initiate a receptor-independent G-protein 
signaling cascade that requires Gf3y as the primary signal transducer. As an example of a 
situation in which Ol3y alone transduces a signal is in early stages of C. elegans 
embryogenesis. Through RNAi studies of both Gf3y and Ga, it was concluded that Gf3y 
directly affects spindle rotation of the first few cell divisions (55). This function would 
match quite well in the Drosophila neuroblast. Recruitment of PINS to apical 
membranes would cause a localized release of Ol3y that would induce the required 90° 
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spindle rotation to occur (Figure 9.1). The presence of BazookalPar-6/aPKC alone 
cannot cause the mitotic spindle to rotate in epithelial cells. However, expression of 
INSC and PINS can cause the mitotic spindle of epithelial cells to properly rotate (156). 
As mentioned in the introduction, the Bazooka/Par-6/aPKC complex likely functions to 
set the apica1/basal poles upon which INSCIPINS translocates in order to initiate spindle 
rotation and asymmetric division. 
If PINS requires Inscuteable alone to be recruited to apical membranes, then 
AGS3 might have an Inscuteable-independent mechanism to undergo translocation. One 
of the authors reporting the discovery of PINS mentioned that PINS could be acting 
independent of Inscuteable, on the basis of subtle differences in their knockout 
phenotypes (173). However, there is strong evidence for a functional interaction between 
the ankyrin repeat region of Inscuteable and the TPR domains of PINS. When analyzed 
by BLAST, Inscuteable does not generate any significant database hits using wither 
nucleotide or protein sequences. Similarly, analysis of translated sequences from EST 
databases does not reveal the existence of Inscuteable homologs. Although there is the 
remote possibility that Inscuteable homlogs in both C. elegans and H. Sapiens genomes 
have yet to be entered, Inscuteable likely represents an insect-specific gene. The ankyrin 
repeat region used to isolate PINS is our best clue to the potential mammalian binding 
partners for AGS3. However, there is another possible site of interaction. Low 
stringency BLAST searches reveal very weak homology between Inscuteable and G-
protein coupled receptors. Schaefer and colleagues mentioned, but did not show, weak: 




Figure 9.1 AGS3 mechanism'. Recruitment of AGS3 to an apical , complex governing cell 
polarity and asymmetric divisions might initiate a receptor independent G-protein signaling 
cascade. Selective activation of G~ effectors would then generate mitotic s piIidle rotation and 
possibly asymmetric cell division. 
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two different proteins could be interacting with AGS3 at apical membranes, one with an 
ankyrin-rich region and another with GPCR-like domains indirectly binding through Ga. 
Function of AGS3 in the adult 
AGS3 protein expression is detected in adult rat brain, implying that AGS3 may 
serve a function outside of development. If neuroblasts are present in the adult brain, 
then AGS3 could play the same role that it plays in the embryo. If not, there are several 
possibilities for its adult function. First, AGS3 might function exclusively as a signal 
regulator. As mentioned above, AGS3 has the potential to affect G-protein signaling by 
selectively activating GJ3y signals, controlling the population of Gia available for 
signaling and desensitizing Gia signaling at the level of G-proteins. The possibility also 
exists for signals to transducer selectively through the AGS3-GiaGDP complex. Second, 
AGS3 could playa role in maintaining cell polarity in neurons. The polarity/asymmetry 
complex or components thereof could localize to specific subdomains of neurons to 
maintain an axis of polarity. Third, AGS3 could direct microtubule formation from 
specific regions of the plasma membrane by initiating a GJ3y signal. A localized 
stimulation of microtubule organization could affect neuron dendrite/axon migration. 
Outside of a potential role in cell polarity and asymmetry, AGS3 may be a general 
G-protein signaling regulator. AGS3 can influence the transfer of signal from receptor to 
G-protein and AGS3 can regulate the activation state of G-proteins independent of 
receptor stimulation. The challenge is to find how AGS3 activity is regulated, when is its 
activity needed and under what physiological conditions its activity is required. Current 
studies are underway to co-crystalize AGS3-GPR with Ga subunits. These data will 
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hopefully map the binding domains of the AGS3-Ga interaction and possibly reveal the 
stoichiometry of the interaction. Assessment of AGS3 function in mammals would be 
greatly facilitated by generation of AGS3 knockout mice as well as by mapping the 
expression of AGS3 through mammalian development. Based on the current interest in 
AGS3 and its family members, we can hopefully look forward to answering these very 
important questions about this intriguing protein. 
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